NPS AND RELATED COMPOUNDS DATABASE |
Substance class |
substance (NPS) common name |
structure (created by OPSIN free tool) |
NPS1 systematic name | other names | Formula per base form |
Mw (g/mol) per base form NPS1 |
MS (BP1) |
MS (BP2) |
MS (BP3) |
GC-MS-RT NFL/min |
MS spectrum (picture) |
StdIn ChIKey |
Type of detection | comments | date of entry |
report updated |
Contributor | Chem-ID or Report-ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indolalkylamines (fe tryptamines) | 5-MeO-N,N-DMT | 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | 5-methoxy-N,N-dimethyltryptamine | C13H18N2O | 218.29 | 58 | 160 | 218 | 7.08 | show | ZSTKHSQDNIGFLM-UHFFFAOYSA-N | RM-reference material | 2006-01-27 | RESPONSE project; 2015-2017 | 610-06A | |||
Piperazine derivates | pCPP | 1-(4-chlorophenyl)piperazine | C10H13ClN2 | 196.67 | 154 | 196 | 138 | 5.42 | show | UNEIHNMKASENIG-UHFFFAOYSA-N | RM-reference material | 2009-04-30 | RESPONSE project; 2015-2017 | 921 | ||||
Piperazine derivates | mCPP | 1-(3-chlorophenyl)piperazine | C10H13ClN2 | 196.67 | 154 | 196 | 138 | 5.38 | show | VHFVKMTVMIZMIK-UHFFFAOYSA-N | RM-reference material | 2010-11-18 | RESPONSE project; 2015-2017 | 962-10A | ||||
Cannabinoids | JWH-250 | 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone | C22H25NO2 | 335.44 | 214 | 144 | 91 | 12.44 | show | FFLSJIQJQKDDCM-UHFFFAOYSA-N | in house RM | 2011-12-01 | RESPONSE project; 2015-2017 | 1021-11A | ||||
Cathinones | Mephedrone | (RS)-2-Methylamino-1-(4-methylphenyl)propan-1-one | 4-methylmethcathinone (4-MMC) | C11H15NO | 177.24 | 58 | 91 | 32 | 3.52 | show | YELGFTGWJGBAQU-UHFFFAOYSA-N | RM-reference material | 2012-02-02 | RESPONSE project; 2015-2017 | 1000-12A | |||
Cathinones | 3-MMC | 2-(Methylamino)-1-(3-methylphenyl)-1-propanone | C11H15NO | 177.24 | 58 | 91 | 119 | 3.41 | show | QDNXSIYWHYGMCD-UHFFFAOYSA-N | RM-reference material | 2012-07-16 | RESPONSE project; 2015-2017 | 1048-12A | ||||
Cathinones | Buphedrone | 2-(methylamino)-1-phenylbutan-1-one | C11H15NO | 177.24 | 72 | 77 | 57 | 3.26 | show | DDPMGIMJSRUULN-UHFFFAOYSA-N | RM-reference material | 2013-05-21 | RESPONSE project; 2015-2017 | 1068-13A | ||||
Cathinones | Butylone | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one | 1-2-(methylamino)-3,4-(methylendioxy)-butyrophenone, bk-MBDB | C12H15NO3 | 221.26 | 72 | 149 | 57 | 5.64 | show | CGKQZIULZRXRRJ-UHFFFAOYSA-N | RM-reference material | 2013-11-28 | RESPONSE project; 2015-2017 | 1079-13A | |||
Cathinones | Naphyrone | (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one | Naphthylpyrovalerone | C19H23NO | 281.39 | 126 | 127 | 155 | 8.87 | show | RM-reference material | 2013-11-28 | RESPONSE project; 2015-2017 | 1081-13A | ||||
Cathinones | 4-MEC | (RS)-2-ethylamino-1-(4-methylphenyl)propan-1-one | C12H17NO | 191.27 | 72 | 44 | 91 | 3.88 | show | ZOXZWYWOECCBSH-UHFFFAOYSA-N | RM-reference material | 2013-11-28 | RESPONSE project; 2015-2017 | 1083-13A | ||||
Indolalkylamines (fe tryptamines) | 5-MeO_MiPT | [2‐(5‐methoxy‐1H‐indol‐3‐yl)ethyl](methyl)(propan‐2‐yl)amine | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine; 5-Methoxy MiPT | C15H22N2O | 246.35 | 86 | 160 | 117 | 8.01 | show | HEDOODBJFVUQMS-UHFFFAOYSA-N | in house RM | NMR confirmed 2018 (RESPONSE-2); analytical report added 2018 | 2013-12-01 | 2018-07-15 | RESPONSE project; 2015-2017 | 1023-11A | |
Cannabinoids | JWH-122 | (4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone | C25H25NO | 355.50 | 355 | 298 | 214 | 16.05 | show | HUKJQMKQFWYIHS-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1025-12A | ||||
Cannabinoids | JWH-018 | Naphthalen-1-yl-(1-pentylindol-3-yl)methanone | C24H23NO | 341.50 | 341 | 214 | 284 | 14.68 | show | JDNLPKCAXICMBW-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1024-12A | ||||
Cannabinoids | FUBIMINA | (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone | AM-2201 benzimidazole analog, BIM-2201, BZ-2201, FTHJ | C23H21FN2O | 360.40 | 271 | 127 | 359 | 14.04 | show | KUESSZMROAFKQJ-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1117-14A | |||
Cannabinoids | JWH-200 | 1-[2-(morpholin-4-yl)ethyl]-3-(naphthalene-1-carbonyl)-1H-indole | (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone | C25H24N2O2 | 384.47 | 100 | 127 | 56 | 18.40 | show | SZWYXJHTNGJPKU-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1019-11A | |||
Cannabinoids | RCS-4 | 2-(4-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone | C21H23NO2 | 321.41 | 321 | 264 | 135 | 12.87 | show | XAEBLSVZPIGTTK-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1022-11A | ||||
Cannabinoids | JWH-203 | 2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone | C21H22ClNO | 339.86 | 214 | 144 | 116 | 12.35 | show | YDINKDBAZJOSLV-UHFFFAOYSA-N | in house RM | 2013-12-01 | RESPONSE project; 2015-2017 | 1020-11A | ||||
Cathinones | bk-MDA | 2-amino-1-(2H-1,3-benzodioxol-5-yl)propan-1-one | 3,4-methylendioxycathinone | C10H11NO3 | 193.20 | 44 | 149 | 121 | 4.94 | show | XDEZOLVDJWWXRG-UHFFFAOYSA-N | RM-reference material | 2014-03-11 | RESPONSE project; 2015-2017 | 1328-16 | |||
Phenethylamines | 2-Fluoroamphetamine | 1-(2-Fluorophenyl)propan-2-amine | 2-fluoro-α-methyl-benzeneethanamine, 2-FA | C9H12FN | 153.20 | 44 | 109 | 83 | 2.28 | show | GDSXNLDTQFFIEU-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1103-14A | |||
Indolalkylamines (fe tryptamines) | 5-MeO-DALT | N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine | 5-methoxy-N,N-diallyltryptamine | C17H22N2O | 270.37 | 110 | 160 | 241 | 8.68 | show | HGRHWEAUHXYNNP-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1108-14A | |||
Piperidines & pyrrolidines | 3,4-CTMP | Methyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate | 3,4-dichloromethylphenidate | C14H17Cl2NO2 | 302.20 | 180 | 181 | 67 | 8.45 | show | JUKMAYKVHWKRKY-CHWSQXEVSA-N | RM-reference material | GC-MS for 3,4-CTMP-TFA derivative; be aware of possible thermal dcomposition, if sample is not derivatized | 2014-09-22 | RESPONSE project; 2015-2017 | 1100-14A | ||
Arylalkylamines | 6-EAPB | 1-(benzofuran-6-yl)-N-ethylpropan-2-amine | C13H17NO | 203.28 | 72 | 44 | 131 | 4.34 | show | MIRNYUKRRZFBOI-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1110-14A | ||||
Cathinones | Ethylone | (RS)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one | C12H15NO3 | 221.25 | 72 | 44 | 149 | 5.53 | show | MJEMIOXXNCZZFK-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1107-14A | ||||
Phenethylamines | 3-Fluoroamphetamine | (RS)-1-(3-Fluorophenyl)propan-2-amine | 3-fluoro-α-methyl-benzeneethanamine, 3-FA | C9H12FN | 153.20 | 44 | 109 | 83 | 2.28 | show | PIOCLGPCMNPZFT-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1102-14A | |||
Cathinones | 2-MMC | 2-(methylamino)-1-(2-methylphenyl)-1-propanone | 2-MMC; 2-methyl MC, 2-methylmethcathinone | C11H15NO | 177.24 | 58 | 91 | 119 | 3.21 | show | PRGXFAWAMOFULD-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1047-12A | |||
Piperidines & pyrrolidines | 2-DPMP | (RS)-2-benzhydrylpiperidine | desoxypipradrol, 2-diphenylmethylpiperidine | C18H21N | 251.37 | 84 | 165 | 56 | 7.35 | show | RWTNXJXZVGHMGI-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1104-14A | |||
Cathinones | Bupropion | (±)-2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one | C13H18ClNO | 239.74 | 44 | 100 | 139 | 4.56 | show | SNPPWIUOZRMYNY-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1101-14A | ||||
Phenethylamines | 2C-D | 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminoethane | C11H17NO2 | 195.26 | 166 | 151 | 135 | 4.46 | show | UNQQFDCVEMVQHM-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1112-14A | ||||
Arylalkylamines | 5-EAPB | 1-(Benzofuran-5-yl)-N-ethylpropan-2-amine | C13H17NO | 203.28 | 72 | 44 | 131 | 4.32 | show | ZBZDDOARNPAMSP-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1111-14A | ||||
Arylalkylamines | 5-MAPB | 1-(Benzofuran-5-yl)-N-methylpropan-2-amine | C12H15NO | 189.25 | 58 | 131 | 77 | 4.00 | show | ZOVRTIPCNFERHY-UHFFFAOYSA-N | RM-reference material | 2014-09-22 | RESPONSE project; 2015-2017 | 1105-14A | ||||
Cathinones | 3,4-MDPV | (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | mehylenedioxypyrovalerone | C16H21NO3 | 275.34 | 126 | 149 | 65 | 7.89 | show | SYHGEUNFJIGTRX-UHFFFAOYSA-N | RM-reference material | 2014-11-28 | RESPONSE project; 2015-2017 | 1084-13A | |||
Cannabinoids | MDMB-CHMCZCA | methyl 2‐{[9‐(cyclohexylmethyl)‐9H‐carbazol‐3‐yl]formamido}‐3,3‐dimethylbutanoate | methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate ; methyl 2-{[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]amino}-3,3-dimethylbutanoate | C27H34N2O3 | 434.58 | 290 | 179 | 291 | 19.85 | show | FAWVRKNYDPKTDZ-UHFFFAOYSA-N | collected | not pure | 2015-01-19 | 2018-05-10 | RESPONSE project; 2015-2017 | 1430-15 | |
Cathinones | alpha-PBP | 1-Phenyl-2-(1-pyrrolidinyl)-1-butanone | C14H19NO | 217.31 | 112 | 77 | 113 | 5.09 | show | GSESDIFGJCCBHN-UHFFFAOYSA-N | collected | mixture with N-Ethyl-norpentylone | 2015-01-19 | Forensic Science Institute Zurich, Switzerland; | 1437-16 | |||
Cannabinoids | 5F-APP-PINACA (PX2) | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | PX2, •FU-PX | C22H25FN4O2 | 396.50 | 233 | 145 | 352 | 16.58 | show | OJTAHWMZBJRSIR-UHFFFAOYSA-N | collected | 2015-01-19 | Hungarian Institute of Forensic Science, Budapest, Hungary | 1400-15 | |||
Cathinones | alpha-PVP | (RS)-1-Phenyl-2-(1-pyrrolidinyl)-1-pentanone | C15H21NO | 231.33 | 126 | 77 | 55 | 5.61 | show | YDIIDRWHPFMLGR-UHFFFAOYSA-N | RM-reference material | 2015-02-16 | RESPONSE project; 2015-2017 | 1151-15A | ||||
Phenethylamines | 4-Methylephedrine | 1-(4-Methylphenyl)-2-methylamino-1-propanol | 2‐(methylamino)‐1‐(4‐methylphenyl)propan‐1‐ol | C11H17NO | 179.26 | 58 | 91 | 77 | 3.65 | show | DUESQFQLBNOCIT-UHFFFAOYSA-N | RM-reference material | 2015-03-04 | RESPONSE project; 2015-2017 | 1346-16 | |||
Phenethylamines | 25I-NBF | N-(2-fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine | 25I-NB2F, 2C-I-NBF, NBF-2C-I, Cimbi-21 | C17H19FINO2 | 415.24 | 109 | 138 | 278 | 10.12 | show | LPBKNBHMWRBPHT-UHFFFAOYSA-N | RM-reference material | 2015-03-04 | 2018-04-13 | RESPONSE project; 2015-2017 | 1376-16 | ||
Cathinones | Pyrovalerone | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | 1-(1-Pyrrolidinyl)butyl p-Tolyl Ketone; Valerophenone, Centroton,Thymergix | C16H23NO | 245.36 | 126 | 127 | 91 | 6.42 | show | SWUVZKWCOBGPTH-UHFFFAOYSA-N | RM-reference material | 2015-03-11 | RESPONSE project; 2015-2017 | 1332-16 | |||
Arylalkylamines | 6-APB | 6-(2-aminopropyl)benzofuran | 1-benzofuran-6-ylpropan-2-amine | C11H13NO | 175.23 | 44 | 131 | 77 | 3.65 | show | FQDAMYLMQQKPRX-UHFFFAOYSA-N | RM-reference material | 2015-03-23 | RESPONSE project; 2015-2017 | 1168-15A | |||
Arylalkylamines | 5-APB | 5-(2-Aminopropyl)benzofuran | 1-benzofuran-5-ylpropan-2-amine | C11H13NO | 175.23 | 44 | 131 | 77 | 3.64 | show | VKUMKUZDZWHMQU-UHFFFAOYSA-N | RM-reference material | 2015-03-23 | RESPONSE project; 2015-2017 | 1167-15A | |||
Cathinones | Pentedrone | (±)-1-phenyl-2-(methylamino)pentan-1-one | α-methylamino-Valerophenone | C12H17NO | 191.27 | 86 | 44 | 105 | 3.71 | show | WLIWIUNEJRETFX-UHFFFAOYSA-N | RM-reference material | 2015-03-23 | RESPONSE project; 2015-2017 | 1166-15A | |||
Cannabinoids | AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | C20H21FN4O2 | 368.41 | 109 | 253 | 324 | 13.29 | show | AKOOIMKXADOPDA-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1116 | ||||
Arylalkylamines | 2-MAPB | 1-(Benzofuran-2-yl)-N-methylpropan-2-amine | 2-[2,N-Dimethyl-2-aminoethyl]benzofuran | C12H15NO | 189.24 | 58 | 131 | 77 | 3.98 | show | ANJIDHKQUCZNQY-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1164 | |||
Cannabinoids | CUMYL-BICA | 1-butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | C22H26N2O | 334.45 | 200 | 216 | 144 | 12.00 | show | BSZWUQMCGNYLJR-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | RESPONSE project; 2015-2017 | 1115 | |||
Cannabinoids | 5F-AMBICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-carboxamide | C19H26FN3O2 | 347.43 | 232 | 144 | 116 | 13.44 | show | GQYZBLMAONPUNX-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1157 | ||||
Cannabinoids | CUMYL-THPINACA | N-(2-phenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-indazole-3-carboxamide | C23H27N3O2 | 377.48 | 243 | 362 | 145 | 14.10 | show | HINCNLQQLQFMRD-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | RESPONSE project; 2015-2017 | 1136 | |||
Cannabinoids | AB-CHMINACA | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | C20H28N4O2 | 356.46 | 241 | 145 | 312 | 13.36 | show | KJNZIEGLNLCWTQ-KRWDZBQOSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1158 | ||||
Cannabinoids | CUMYL-PINACA | 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | C22H27N3O | 349.46 | 215 | 145 | 334 | 11.40 | show | LCBASRYREGWIJT-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | RESPONSE project; 2015-2017 | 1135 | |||
Cannabinoids | ADB-CHMICA | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanamide | C22H31N3O2 | 369.50 | 240 | 144 | 55 | 15.80 | show | LPXKQKOUEIQHLR-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1113 | |||
Cannabinoids | 5F-PB22-mixAKB48 | 8-Quinolinyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester | C23H21FN2O2 | 376.40 | 232 | 144 | 116 | 17.10 | show | MBOCMBFDYVSGLJ-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1162 | |||
Cannabinoids | FUB-AKB48 | N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | AKB-48-fluorobenzyl analogue | C25H26FN3O | 403.49 | 109 | 253 | 294 | 17.14 | show | MWBHSNBPUSKVDD-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1159 | |||
Cannabinoids | Cumyl-5F-P7AICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-7-azaindole-3-carboxamide | N-cumyl-(5-fluoropentyl)-7-azaindole-3-carboxamide, SGT-263 | C22H26FN3O | 367.50 | 233 | 145 | 117 | 12.85 | show | MXJYOUMYJGNQEY-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | 2016-03-13 | RESPONSE project; 2015-2017 | 1154 | |
Others | Dimethocaine | (3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate | larocaine, DMC | C16H26N2O2 | 278.39 | 86 | 120 | 8.31 | show | OWQIUQKMMPDHQQ-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1161 | ||||
Cathinones | N-ethylnorpentedrone | 1-phenyl-2-(ethylamino)pentan-1-on | N-ethlyaminopentiophenone; a-ethlyaminopentiophenon; N-Ethylpentylone | C13H19NO | 205.30 | 100 | 58 | 77 | 4.05 | show | QQAHEGDXEXIQPR-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1153 | |||
Cannabinoids | CUMYL-PICA | 1-(5-pentyl)-N-(2-phenylpropane-2-yl)-1H-indole-3-carboxamide | C23H28N2O | 348.48 | 214 | 230 | 144 | 13.00 | show | RCXFMWJQOYCIQU-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | RESPONSE project; 2015-2017 | 1114 | |||
Cannabinoids | AKB48 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide | APINACA | C23H31N3O | 365.10 | 215 | 145 | 294 | 14.33 | show | UCTCCIPCJZKWEZ-UHFFFAOYSA-N | seized | impurities detected | 2015-03-27 | RESPONSE project; 2015-2017 | 1162 | ||
Cathinones | 3-CMC | 1-(3-chlorophenyl)-2-(methylamino)propan-1-one | 3-chloromethcathinone; Clophedrone | C10H12ClNO | 197.70 | 58 | 75 | 111 | 3.77 | show | VOEFELLSAAJCHJ-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1152 | |||
Cannabinoids | ADAMANTYL-THPINACA | N-(1-adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide | C24H31N3O2 | 393.52 | 135 | 243 | 145 | 17.52 | show | WFDRVDUEMGJILX-UHFFFAOYSA-N | seized | 2015-03-27 | 2016-05-25 | RESPONSE project; 2015-2017 | 1160 | |||
Cannabinoids | CUMYL-5F-PINACA | 1-(5-fluoropentyl)-N-(2-phenylpropane-2-yl)-1H-indazole-3-carboxamide | 5-fluoro Cumyl-pinaca, SGT 25 | C22H26FN3O | 367.46 | 233 | 145 | 352 | 12.05 | show | XSHGVIPHMOTDCS-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | 2015-11-04 | RESPONSE project; 2015-2017 | 1155 | |
Cannabinoids | PB-22 | 8-Quinolinyl 1-pentyl-1H-indole-3-carboxylate | QUPIC, | C23H22N2O2 | 358.43 | 214 | 144 | 116 | 16.31 | show | ZAVGICCEAOUWFM-UHFFFAOYSA-N | seized | 2015-03-27 | RESPONSE project; 2015-2017 | 1165-15A | |||
Cannabinoids | CUMYL-5F-PICA | 1-(5-fluoropentyl)-N-(2-phenylpropane-2-yl)-1H-indole-3-carboxamide | C23H27FN2O | 366.47 | 232 | 248 | 144 | 13.90 | show | ZJCYQNSYQBCKOD-UHFFFAOYSA-N | seized | https://www.policija.si/eng/images/stories/GPUNFL/PDF/P-083_Prague2015_SyntheticCannabinoids_Poster-final.pdf | 2015-03-27 | RESPONSE project; 2015-2017 | 1118 | |||
Piperidines & pyrrolidines | Isopropylphenidate | isopropyl 2‐phenyl‐2‐(piperidin‐2‐yl)acetate | propan‐2‐yl 2‐phenyl‐2‐(piperidin‐2‐yl)acetate | C16H23NO2 | 261.36 | 84 | 91 | 43 | 5.87 | show | AZVPADMEIMLODT-UHFFFAOYSA-N | test purchase | 2015-04-17 | RESPONSE project; 2015-2017 | 1171-15 | |||
Benzodiazepines | Deschloroetizolam | 2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H16N4S | 308.4 | 279 | 308 | 239 | 13.08 | show | JIOBORXCOGMHSV-UHFFFAOYSA-N | test purchase | 2015-04-17 | RESPONSE project; 2015-2017 | 1174-15 | ||||
Arylalkylamines | 5-APB NBOMe | 1-(benzofuran-5-yl)-N-(2-methoxybenzyl)propan-2-amine | C19H21NO2 | 295.38 | 121 | 164 | 91 | 8.92 | show | NSWWDACHSBMHLV-UHFFFAOYSA-N | test purchase | 2015-04-17 | RESPONSE project; 2015-2017 | 1175-15 | ||||
Others | 3-FPM | 2-(3-fluorophenyl)-3-methylmorpholine | 3-Fluorophenmetrazine | C11H14FNO | 195.23 | 71 | 42 | 56 | 3.49 | show | VHYVKJAQSJCYCK-UHFFFAOYSA-N | test purchase | 2015-04-17 | RESPONSE project; 2015-2017 | 1172-15 | |||
Arylcyclohexylamines | 3-MeO-PCP | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | 3-Methoxyphencyclidine | C18H27NO | 273.41 | 230 | 272 | 273 | 7.83 | show | BQQSZHHKGPOXLN-UHFFFAOYSA-N | collected | NOT analyzed by NMR | 2015-05-13 | RESPONSE project; 2015-2017 | 233-1890/2015 | ||
Benzodiazepines | Nifoxipam | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one | 5-(2-fluorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C15H10FN3O4 | 315.26 | 223 | 222 | 75 | 9.37 | show | UHFIFTRHLBAWGY-UHFFFAOYSA-N | collected | 2015-05-13 | RESPONSE project; 2015-2017 | 233-1918/15 | |||
Others | 3-FPM-crystal | 2-(3-fluorophenyl)-3-methylmorpholine | 3-Fluorophenmetrazine | C11H14FNO | 195.23 | 71 | 42 | 56 | 3.49 | show | VHYVKJAQSJCYCK-UHFFFAOYSA-N | test purchase | 2015-05-13 | RESPONSE project; 2015-2017 | 1173-15 | |||
Benzodiazepines | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | clontrazolam | C17H12ClN5O2 | 353.76 | 324 | 249 | 203 | 15.59 | show | XJRGLCAWBRZUFC-UHFFFAOYSA-N | collected | 2015-05-13 | RESPONSE project; 2015-2017 | 233-1980/2015 | |||
Phenethylamines | 25IP-NBOMe | {2‐[2,5‐dimethoxy‐4‐(propan‐2‐yl)phenyl]ethyl}[(2‐methoxyphenyl)methyl]amine | [2‐(4‐isopropyl‐2,5‐dimethoxyphenyl)ethyl][(2‐methoxyphenyl)methyl]amine | C21H29NO3 | 343.47 | 121 | 150 | 91 | 9.83 | show | KMZZEEDFQLXSQF-UHFFFAOYSA-N | test purchase | 2015-05-15 | RESPONSE project; 2015-2017 | 1176-15 | |||
Phenethylamines | DOF | 1‐(4‐fluoro‐2,5‐dimethoxyphenyl)propan‐2‐amine | DOF | C11H16FNO2 | 213.25 | 44 | 170 | 155 | 4.07 | show | NRANUECGGQVXOT-UHFFFAOYSA-N | test purchase | purchased as 4-AcO-DPT; DOF is mixed with DOIP; DOF was confirmed by reference material ID 1413-15 (24/12/2015) | 2015-05-15 | RESPONSE project; 2015-2017 | 1178-15 | ||
Phenethylamines | DOIP | 1‐[2,5‐dimethoxy‐4‐(propan‐2‐yl)phenyl]propan‐2‐amine | 1‐(4‐isopropyl‐2,5‐dimethoxyphenyl)propan‐2‐amine | C14H23NO2 | 237.34 | 44 | 194 | 179 | 5.12 | show | SPKSLAUXKHSASF-UHFFFAOYSA-N | test purchase | purchased as 4-AcO-DALT | 2015-05-15 | RESPONSE project; 2015-2017 | 1177-15 | ||
Phenethylamines | 4-chloro-2,5-DMA | 1-(4-Chloro-2,5-dimethoxy-phenyl)propan-2-amine | 4-chloro-2,5-dimethoxy-a-methyl-benzeneethanamine, 4-chloro-2,5-dimethoxyamphetamine, DOC | C11H16ClNO2 | 229.70 | 44 | 186 | 77 | 5.34 | show | ACRITBNCBMTINK-UHFFFAOYSA-N | RM-reference material | 2015-06-01 | RESPONSE project; 2015-2017 | 1180-15 | |||
Cannabinoids | 5F-AKB48 | N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3 –carboxamide | APINACA 5-fluoropentyl analog; 5F-APINACA, AKB48-5F | C23H30FN3O | 383.51 | 233 | 145 | 294 | 15.65 | show | UCMFSGVIEPXYIV-UHFFFAOYSA-N | seized | Analytical report added (12/02/16) | 2015-06-03 | 2016-02-12 | RESPONSE project; 2015-2017 | 1179-15 | |
Piperazine derivates | DB-MDBP | 1-((2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)METHYL)PIPERAZINE | C12H14F2N2O2 | 256.25 | 171 | 214 | 256 | 4.73 | show | MPZINTHEMFDGTH-UHFFFAOYSA-N | test purchase | 2015-07-11 | 2018-04-11 | RESPONSE project; 2015-2017 | 1185-15 | |||
Cannabinoids | AB-CHFUPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H -pyrazole-5-carboxamide | AB-CHMFUPPYCA; 3,5-AB-CHMFUPPYCA | C22H29FN4O2 | 400.50 | 257 | 189 | 95 | 15.05 | show | NDYOOVJIZQTGHY-UHFFFAOYSA-N | test purchase | purchased as AZ-037 | 2015-07-11 | RESPONSE project; 2015-2017 | 1181-15 | ||
Cathinones | 5-BPDi | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | C19H27NO | 285.42 | 140 | 115 | 96 | 8.59 | show | WETQQOQCDBNIKE-UHFFFAOYSA-N | test purchase | purchased as 5-PPDi | 2015-07-11 | RESPONSE project; 2015-2017 | 1183-15 | |||
Cannabinoids | 5C-AKB48 | N-(1-adamantyl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide | 5C-APINACA, 5Cl-AKB48 | C23H30ClN3O | 399.96 | 249 | 145 | 294 | 17.39 | show | LGENBCKWDLSPTD-UHFFFAOYSA-N | test purchase | 2015-07-13 | 2015-10-16 | RESPONSE project; 2015-2017 | 1186-15 | ||
Cathinones | N-methyl-bk-MMDA-2 | 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | N-Me-bk-MMDA-2 | C12H15NO4 | 237.25 | 58 | 179 | 164 | 6.38 | show | SONSUHOOEIVPFR-UHFFFAOYSA-N | test purchase | purchased as 2-AiMP | 2015-07-13 | RESPONSE project; 2015-2017 | 1182-15 | ||
Others | 2-MeO-Diphenidine | 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine | Methoxyphenidine, MXP | C20H25NO | 295.42 | 204 | 205 | 91 | 8.23 | show | QXXCUXIRBHSITD-UHFFFAOYSA-N | seized | 2015-07-17 | RESPONSE project; 2015-2017 | 1163-15A | |||
Cannabinoids | FUBIMINA | (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone | AM-2201 benzimidazole analog, BIM-2201, BZ-2201, FTHJ | C23H21FN2O | 360.40 | 271 | 127 | 359 | 14.12 | show | KUESSZMROAFKQJ-UHFFFAOYSA-N | test purchase | purchased as THJ-018 | 2015-07-22 | RESPONSE project; 2015-2017 | 1198-15 | ||
Cannabinoids | MDMB-CHMICA | N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-valine, methyl ester | MMB-CHMINACA | C23H32N2O3 | 384.51 | SRJKCVHWIDFUBO-HXUWFJFHSA-N | test purchase | purchased as MMB-CHMINACA | 2015-07-22 | RESPONSE project; 2015-2017 | 1193-15 | |||||||
Phenethylamines | 2C-C | 1-(4-Chloro-2,5-dimethoxyphenyl)-2-aminoethane | 4-Chloro-2,5-dimethoxy-phenethylamine | C10H14ClNO2 | 215.68 | 186 | 171 | 77 | 5.23 | show | CGKQFIWIPSIVAS-UHFFFAOYSA-N | RM-reference material | 2015-07-29 | RESPONSE project; 2015-2017 | 1109-14A | |||
Cannabinoids | STS-135 | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 5F-APICA | C24H31FN2O | 382.50 | 232 | 382 | 144 | 17.47 | show | COYHGVCHRRXECF-UHFFFAOYSA-N | test purchase | 2015-07-29 | RESPONSE project; 2015-2017 | 1200-15 | |||
Benzodiazepines | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C16H12Cl2N2O | 319.19 | 283 | 318 | 290 | 10.08 | show | VPAYQWRBBOGGPY-UHFFFAOYSA-N | test purchase | 2015-07-29 | RESPONSE project; 2015-2017 | 1197-15 | ||||
Cathinones | 5-DBFPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | 5-dihydrobenzofuranpyrovalerone | C17H23NO2 | 273.37 | 126 | 127 | 147 | 8.40 | show | CIGWUZUBQBQZAO-UHFFFAOYSA-N | test purchase | 2015-08-19 | 2015-10-15 | RESPONSE project; 2015-2017 | 1251-15 | ||
Cathinones | 3,4-dimethoxy-alpha-PHP | 1-(3,4-dimethoxyphenyl)-2-(pyrrolidin-1-yl)hexan-1-one | 3,4-DMeO-α-PHP | C18H27NO3 | 305.41 | 140 | 141 | 96 | 8.68 | show | KAWWDIAYCGMAPE-UHFFFAOYSA-N | test purchase | 2015-08-19 | 2015-11-09 | RESPONSE project; 2015-2017 | 1250-15 | ||
Piperazine derivates | DB-MDBP | 1-((2,2-difluorobenzo[D][1,3]dioxol-5-yl)methyl)piperazine | C12H14F2N2O2 | 256.25 | 171 | 214 | 56 | 4.73 | show | MPZINTHEMFDGTH-UHFFFAOYSA-N | test purchase | 2015-08-19 | 2018-04-11 | RESPONSE project; 2015-2017 | 1252-15 | |||
Others | 4-MPH | 3-methyl-2(p-tolyl)morpholine | 3-methyl-2-(4-methylphenyl)morpholine, 4-MPM, mephenmetrazine, 4-methylphenmetrazine | C12H17NO | 191.27 | 71 | 56 | 42 | 4.17 | show | NWNCIXFIIDVRKE-UHFFFAOYSA-N | test purchase | source I | 2015-08-19 | RESPONSE project; 2015-2017 | 1243-15 | ||
Cathinones | MDPHP | 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-yl-hexan-1-one | MD-PHP | C17H23NO3 | 289.37 | 140 | 141 | 149 | 8.40 | show | OBLFRFGUZZRECT-UHFFFAOYSA-N | test purchase | 25% of an unknown organic impurity by NMR | 2015-08-19 | RESPONSE project; 2015-2017 | 1245-15 | ||
Piperidines & pyrrolidines | HDEP-28 | ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate | ethylnaphtidate, HDEP-28, 2-(2-ethoxy-1-(naphthalen-2-yl)-2-oxoethyl)piperidin | C19H23NO2 | 297.17 | 180 | 214 | 181 | 9.58 | show | OTQVTBPHZRARTL-UHFFFAOYSA-N | test purchase | GC-RT and MS spectrum refer to HDEP-28-TFA derivative; for more information read the Analytical report | 2015-08-19 | RESPONSE project; 2015-2017 | 1244-15 | ||
Piperidines & pyrrolidines | HDEP-28-thermal-decomposition | ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate | ethylnaphtidate, HDEP-28, 2-(2-ethoxy-1-(naphthalen-2-yl)-2-oxoethyl)piperidin | C19H23NO2 | 297.17 | 141 | 214 | 115 | 5.65 | show | OTQVTBPHZRARTL-UHFFFAOYSA-N | test purchase | GC-RT and MS spectrum refers to HDEP-28 decomposition product; for more information read the Analytical report | 2015-08-19 | RESPONSE project; 2015-2017 | 1244-15 | ||
Cannabinoids | AMB-CHMICA | methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3-methylbutanoate | methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)valinate; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carbonylamino)-3-methylbutanoate; MMB-CHMICA Cayman (L-stereoisomere defined) | C22H30N2O3 | 370.48 | 240 | 256 | 144 | 13.53 | show | ROWZIXRLVUOMCJ-UHFFFAOYSA-N | test purchase | purchased as MA-CHMINACA; and another one as MAB-CHMINACA | 2015-08-19 | 2015-10-22 | RESPONSE project; 2015-2017 | 1248-15 | |
Cannabinoids | JWH-072-N-carboxy | 3-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]propanoic acid | C22H17NO3 | 343.38 | 270 | 415 | 127 | 16.45 | show | VCRZMEAJRGIGCT-UHFFFAOYSA-N | RM-reference material | for GC-MS compound was derivatized by MSTFA: GC-RT and MS spectrum refer for TMS derivative; | 2015-08-22 | 2015-11-07 | RESPONSE project; 2015-2017 | 1288-15 | ||
Phenethylamines | 25C-NBOH | 2-((4-chloro-2,5-dimethoxyphenethylamino)methyl)phenol | 2C-C-NBOH, NBOH-2CC | C17H20ClNO3 | 321.80 | 179.00 | 280 | 73 | 10.74 | show | VHWXICYYQMMZCW-UHFFFAOYSA-N | RM-reference material | for GC-MS compound was derivatized by MSTFA: GC-RT and MS spectrum refer for TMS derivative | 2015-08-22 | 2018-07-15 | RESPONSE project; 2015-2017 | 1217-15 | |
Benzodiazepines | Phenazepam 4-oxide | 7-bromo-5-(2-chlorophenyl)-4-hydroxy-3,4-dihydro-2H-1,4-benzodiazepin-2-one | Phenazepam-4-okside (Chiron name), Phenazepam-4-hydroxy | C15H10BrClN2O2 | 365.61 | 286 | 288 | 330 | 13.12 | show | YNKDPCTZJPAZJC-UHFFFAOYSA-N | RM-reference material | 2015-08-22 | 2015-11-07 | RESPONSE project; 2015-2017 | 1236-15 | ||
Phenethylamines | 3-Bromoamphetamine | 3-bromo-α-methyl-benzeneethanamine | (DL-) 3-Bromoamphetamine | C9H12BrN | 214.11 | 44 | 89 | 90 | 3.26 | show | ATRSAWXXYCBXLI-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1208-15 | |||
Cannabinoids | RCS-8 | 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole | C25H29NO2 | 375.50 | 254 | 255 | 144 | 16.45 | show | BSQFBMXCQIKYNI-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1232-15 | ||||
Cannabinoids | HU-308 | [(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol | C27H42O3 | 414.62 | 277 | 353 | 318 | 11.22 | show | CFMRIVODIXTERW-BHIFYINESA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1226-15 | ||||
Cannabinoids | 5F-APICA | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | STS-135 | C24H31FN2O | 382.51 | 232 | 382 | 144 | 17.46 | show | COYHGVCHRRXECF-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1225-15 | |||
Phenethylamines | 2-Bromomethamphetamine | 1-(2-bromophenyl)-n-methylpropan-2-amine | (DL-)2-Bromomethamphetamine | C10H14BrN | 228.13 | 58 | 89 | 169 | 3.48 | show | DKQQZKGGVNMTBO-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1212-15 | |||
Cannabinoids | JWH-147 | (1-hexyl-5-phenyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone | 1-Hexsyl-3-(naphtoyl)-5-phenyl-pyrrol | C27H27NO | 381.51 | 381 | 155 | 127 | 16.70 | show | FRMYAMAGHYHNKF-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1230-15 | |||
Cannabinoids | AB-PINACA | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide | C18H26N4O2 | 330.43 | 215 | 286 | 145 | 11.06 | show | GIMHPAQOAAZSHS-HNNXBMFYSA-N | RM-reference material | 2015-08-31 | 2015-11-05 | RESPONSE project; 2015-2017 | 1221-15 | |||
Cannabinoids | JWH-020 | (1-heptyl-1H-indol-3-yl)-1-naphthalenyl-methanone | 1-heptyl-3-(naphtoyl)indole | C26H27NO | 369.50 | 369 | 284 | 242 | 16.59 | show | IHKDUDCDUKFOKK-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1228-15 | |||
Cannabinoids | JWH-072 | 1-naphthalenyl(1-propyl-1H-indol-3-yl)-methanone | C22H19NO | 313.39 | 313 | 186 | 127 | 13.01 | show | IVLWWVXVWRIXSS-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1229-15 | ||||
Cannabinoids | JWH-018 methylderivate (2-methylnaphthalene | (2-methylnaphthalen-1-yl)-(1-pentyl-1H-indol-3-yl)methanone | C25H25NO | 355.47 | 355 | 168 | 298 | 14.25 | show | JFJAWRDBCAFLQA-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1227-15 | ||||
Piperidines & pyrrolidines | Diphenidine | 1-(1,2-Diphenylethyl)piperidine | 1,2-diphenylethylpiperidine; AC1L4H21; BRD-A86415025-103-01-7; DPD; 1,2-DEP; DIPH | C19H23N | 265.39 | 174 | 91 | 175 | 7.43 | show | JQWJJJYHVHNXJH-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1238-15 | |||
Piperazine derivates | 1-(2,5-Dimethoxybenzyl)piperazine | 1-(2,5-Dimethoxybenzyl)piperazine | C13H20N2O2 | 236.32 | 151 | 194 | 121 | 6.58 | show | KITIJFNTLBMYQD-UHFFFAOYSA-N | RM-reference material | Typing error corrected. | 2015-08-31 | 2016-03-13 | RESPONSE project; 2015-2017 | 1218-15 | ||
Benzodiazepines | 3-Hydroxyphenazepam | 7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C15H10BrClN2O2 | 365.61 | 320 | 318 | 75 | 9.84 | show | KRJKJUWAZOWXNV-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1235-15 | ||||
Cannabinoids | AM-2233 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole | C22H23IN2O | 458.33 | 98 | 70 | 231 | 16.50 | show | KSLCYQTUSSEGPT-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1224-15 | ||||
Benzodiazepines | Bentazepam | 5-phenyl-3,5a,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e][1,4]diazepin-2-one | Thiadipone | C17H16N2OS | 296.39 | 267 | 296 | 268 | 11.49 | show | LDKXEWJIVTUBFI-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1234-15 | |||
Arylcyclohexylamines | Methoxetamine(MXE) | (RS)2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | C15H21NO2 | 247.33 | 190 | 219 | 134 | 6.47 | show | LPKTWLVEGBNOOX-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1237-15 | ||||
Phenethylamines | 3-Bromomethamphetamine | 1-(3-bromophenyl)-n-methylpropan-2-amine | (DL-)3-Bromomethamphetamine | C10H14BrN | 228.13 | 58 | 89 | 90 | 3.58 | show | NJECBXFYELEKOF-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1213-15 | |||
Others | para-Methyl-4-methylaminorex | 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine | C11H14N2O | 190.24 | 70 | 43 | 69 | 5.02 | show | NPILLHMQNMXXTL-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1240-15 | ||||
Phenethylamines | 2-Methoxymethamphetamine | 1-(2-methoxyphenyl)-N-methyl-propan-2-amine | C11H17NO | 179.26 | 58 | 91 | 78 | 3.09 | show | OEHAYUOVELTAPG-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1215-15 | ||||
Piperidines & pyrrolidines | Prolintane | 1-(1-Benzylbutyl)pyrrolidine | C15H23N | 217.35 | 126 | 127 | 91 | 4.75 | show | OJCPSBCUMRIPFL-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1241-15 | ||||
Piperazine derivates | 1-(3-Methoxyphenyl)piperazine | 1-(3-Methoxyphenyl)piperazine | C11H16N2O | 192.26 | 150 | 192 | 135 | 5.59 | show | PZIBVWUXWNYTNL-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1219-15 | ||||
Others | Methoxphenidine | 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine | MXP, 2-MXD, 2-MeO-Diphenidine | C20H25NO | 295.42 | 204 | 205 | 91 | 8.22 | show | QXXCUXIRBHSITD-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1239-15 | |||
Phenethylamines | 4-Bromomethamphetamine | 1-(4-bromophenyl)-n-methylpropan-2-amine | C10H14BrN | 228.13 | 58 | 89 | 90 | 3.67 | show | RHHFGACRACGCQS-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1214-15 | ||||
Phenethylamines | 4-Bromoamphetamine | 4-bromo-α-methyl-benzeneethanamine | C9H12BrN | 214.11 | 44 | 89 | 90 | 3.34 | show | SMNXUMMCCOZPPN-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1209-15 | ||||
Piperazine derivates | 1-(2,3,4-Trimethoxybenzyl)piperazine | 1-(2,3,4-trimethoxybenzyl)piperazine | trimetazidine | C14H22N2O3 | 266.34 | 181 | 85 | 166 | 7.09 | show | UHWVSEOVJBQKBE-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1220-15 | |||
Phenethylamines | 2-Methoxyamphetamine | 1-(2-methoxyphenyl)propan-2-amine | C10H15NO | 165.23 | 44 | 91 | 122 | 2.85 | show | VBAHFEPKESUPDE-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1210-15 | ||||
Phenethylamines | 3-Methoxyamphetamine | 1-(3-methoxyphenyl)propan-2-amine | C10H15NO | 165.23 | 44 | 91 | 122 | 3.01 | show | VEJWNIYARKAHFI-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1211-15 | ||||
Phenethylamines | 2-Bromoamphetamine | 2-bromo-α-methyl-benzeneethanamine | (DL-) 2-Bromoamphetamine | C9H12BrN | 214.11 | 44 | 89 | 90 | 3.16 | show | VGJBPBDFJNFFRO-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1207-15 | |||
Cannabinoids | 5F-AB-PINACA | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | AB-PINACA 5-fluoro | C18H25FN4O2 | 348.42 | 233 | 304 | 145 | 11.76 | show | WCBYXIBEPFZUBG-HNNXBMFYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1222-15 | |||
Cathinones | 4-Hydroxymethcathinone | 1-(4-hydroxy-phenyl)-2-methylamino-propan-1-one | C10H13NO2 | 179.22 | 58 | 121 | 39 | 4.97 | show | WYLPQOVNOVHCLO-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1216-15 | ||||
Cannabinoids | UR-144-N-(4-Hydroxypentyl)-metabolite | (1-(4-hydroxypentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | C21H29NO2 | 327.46 | 230 | 144 | 312 | 10.84 | show | YHFHYHZNLCEAAP-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1233-15 | ||||
Phenethylamines | Acetylamphetamine | N-(1-Methyl-2-phenylethyl)acetamide | DL-Acetylamphetamine | C11H15NO | 177.24 | 44 | 86 | 118 | 3.73 | show | YPKBVWZHVTZSPU-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1206-15 | |||
Arylcyclohexylamines | Ketamine | (RS)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone | C13H16ClNO | 237.73 | 180 | 182 | 209 | 6.27 | show | YQEZLKZALYSWHR-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1242-15 | ||||
Cannabinoids | A-796260 | [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone | LTI-258 | C22H30N2O2 | 354.49 | 100 | 114 | 101 | 12.05 | show | ZCFHOMLAFTWDFM-UHFFFAOYSA-N | RM-reference material | 2015-08-31 | RESPONSE project; 2015-2017 | 1223-15 | |||
Arylcyclohexylamines | 3-MEO-PCP | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | C18H27NO | 273.42 | 230 | 272 | 273 | 7.87 | show | BQQSZHHKGPOXLN-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-06 | RESPONSE project; 2015-2017 | 1262-15 | |||
Arylalkylamines | 5-MBPB | 1-(benzofuran-5-yl)-N-methylbutan-2-amine | 5-MBPB | C13H17NO | 203.28 | 72 | 131 | 77 | 4.61 | show | CTEZPBCLIKEASW-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-03 | RESPONSE project; 2015-2017 | 1260-15 | ||
Opioids | 4-MEO-BF | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide | C24H32N2O2 | 380.53 | 289 | 176 | 219 | 13.46 | show | FNVSEQCPMXWQKG-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-05 | RESPONSE project; 2015-2017 | 1263-15 | |||
Cathinones | 4-MEO-PVP | 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | C16H23NO2 | 261.36 | 126 | 127 | 135 | 7.39 | show | HWYVHRCKBXGZLV-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-02 | RESPONSE project; 2015-2017 | 1268-15 | |||
Indolalkylamines (fe tryptamines) | 4-HO-MET | 3-(2-(ethyl(methyl)amino)ethyl)-1H-indol-4-ol | 4-hydroxy-N-methyl-N-ethyltryptamine | C13H18N2O | 218.30 | 72 | 218 | 146 | 7.51 | show | ORWQBKPSGDRPPA-UHFFFAOYSA-N | test purchase | substantial amount of fumaric acid detected | 2015-09-02 | 2015-12-01 | RESPONSE project; 2015-2017 | 1267-15 | |
Arylalkylamines | 5-MAPDB | 1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine | 5-MAPDB | C12H17NO | 191.27 | 58 | 134 | 133 | 4.51 | show | PLQTZOCLUHHCOI-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-02 | RESPONSE project; 2015-2017 | 1264-15 | ||
Opioids | 4F-BF | 1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one | 4F-BF/4-fluoro-butyrfentanyl | C23H29FN2O | 368.49 | 277 | 164 | 207 | 11.29 | show | QZFMCYUBPSLOBP-UHFFFAOYSA-N | test purchase | pure by GC,HPLC, organic impurities detected by NMR | 2015-09-02 | 2015-12-02 | RESPONSE project; 2015-2017 | 1259-15 | |
Benzodiazepines | FLUBROMAZOLAM | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | C17H12BrFN4 | 371.21 | 222 | 343 | 341 | 13.20 | show | VXGSZBZQCBNUIP-UHFFFAOYSA-N | test purchase | 2015-09-02 | 2015-11-06 | RESPONSE project; 2015-2017 | 1265-15 | |||
Cannabinoids | 5F-MN-18 | 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide | 5F-MN-18, 5-fluoro-MN-18, AM-2201 indazole carboxamide analogue | C23H22FN3O | 375.44 | 233 | 145 | 375 | 17.62 | show | XBSWUIWDRFCAGZ-UHFFFAOYSA-N | test purchase | CORRECTION: Incorrect identification data (substance reported as 5F-PCN) was removed at 10th March 2016. Sample was purchased as 5F-ADB. | 2015-09-02 | 2016-03-22 | RESPONSE project; 2015-2017 | 1261-15 | |
Cannabinoids | 5F-AMB | methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate | 5F-AMP | C19H26FN3O3 | 363.43 | 233 | 304 | 145 | 10.49 | show | SAFXSUZMRLTBMM-UHFFFAOYSA-N | test purchase | purchased as FUB144 | 2015-09-10 | 2015-11-03 | RESPONSE project; 2015-2017 | 1269-15 | |
Cannabinoids | 5F-APP-PICA_(PX1) | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | PX1 | C23H26FN3O2 | 395.47 | 232 | 144 | 248 | 18.47 | show | DDVANTXQCRMRFF-UHFFFAOYSA-N | test purchase | purchased as 5F-APP-PINACA | 2015-09-16 | 2015-12-14 | RESPONSE project; 2015-2017 | 1271-15 | |
Cannabinoids | 5F-APP-PICA(PX1)-see ID-1271-15 | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | PX1 | C23H26FN3O2 | 395.47 | 232 | 144 | 248 | 18.54 | show | DDVANTXQCRMRFF-UHFFFAOYSA-N | test purchase | analytical results were identical as for ID: 1271-15 (see the analytical report there) | 2015-09-16 | RESPONSE project; 2015-2017 | 1270-15 | ||
Cathinones | 5-PPDi | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | C17H23NO | 257.37 | 112 | 113 | 115 | 7.73 | show | HLBROWUOAAQHCM-UHFFFAOYSA-N | test purchase | 2015-09-30 | RESPONSE project; 2015-2017 | 1205-15 | ||||
Arylalkylamines | MPA-Methiopropamine | N-Methyl-1-(thiophen-2-yl)propan-2-amine | MPA, methylthienylpropamine | C8H13NS | 155.26 | 58 | 97 | 56 | 2.37 | show | HPHUWHKFQXTZPS-UHFFFAOYSA-N | test purchase | 2015-09-30 | RESPONSE project; 2015-2017 | 1194-15 | |||
Cannabinoids | 5F-PY-PICA | 1-(5-fluoropentyl)-3-(pyrrolidine-1-carbonyl)-1H-indole | (1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)methanone | C18H23FN2O | 302.39 | 232 | 144 | 302 | 11.45 | show | AJOAHRJLOXOZKX-UHFFFAOYSA-N | test purchase | sample was purchased as 5F-AMP-indole [(N-(cyclopropylmethyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide] | 2015-10-04 | 2015-12-02 | RESPONSE project; 2015-2017 | 1281-15 | |
Cannabinoids | APP-CHMINACA_(PX3) | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | PX3 | C24H28N4O2 | 404.50 | 241.1 | 145 | 360 | 18.45 | show | DMHWDSGURMXMGE-UHFFFAOYSA-N | test purchase | compound is not pure | 2015-10-04 | 2016-01-04 | RESPONSE project; 2015-2017 | 1280-15 | |
Benzodiazepines | ADINAZOLAM | 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | Adinazolamum; Deracyn | C19H18ClN5 | 351.83 | 308 | 310 | 309 | 13.47 | show | GJSLOMWRLALDCT-UHFFFAOYSA-N | test purchase | Compound is not pure by NMR, contains a minor amount of organic ipurities | 2015-10-04 | 2015-12-09 | RESPONSE project; 2015-2017 | 1277-15 | |
Cathinones | NEB | 2-(ethylamino)-1-phenylbutan-1-one | N-ethyl buphedrone | C12H17NO | 191.47 | 86 | 77 | 58 | 3.55 | show | HEPVRDHGUWFXJS-UHFFFAOYSA-N | test purchase | pure by GC-MS, HPLC-TOF, not pure by NMR - see analytical report | 2015-10-04 | 2015-12-12 | RESPONSE project; 2015-2017 | 1287-15 | |
Cathinones | alpha-PHP | 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one | α-PHP, alpha-PHP, α-Pyrrolidinohexanophenone, PV-7 | C16H23NO | 245.36 | 140 | 141 | 77 | 6.23 | show | KYIJLDDXQWBNGX-UHFFFAOYSA-N | test purchase | 2015-10-04 | 2016-12-08 | RESPONSE project; 2015-2017 | 1283-15 | ||
Cathinones | TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one | C19H27NO | 285.43 | 126 | 127 | 91 | 8.79 | show | MMIKQWIZKBYLKZ-UHFFFAOYSA-N | test purchase | 2015-10-04 | 2016-12-08 | RESPONSE project; 2015-2017 | 1278-15 | |||
Cathinones | 4-Cl-PVP | 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one | C15H20ClNO | 265.78 | 126 | 127 | 111 | 6.75 | show | NIGBFBTVONRYQN-UHFFFAOYSA-N | test purchase | purchased as 4-MeO-PV9 | 2015-10-04 | 2016-12-08 | RESPONSE project; 2015-2017 | 1279-15 | ||
Cathinones | 4F-NPP | 1‐(4‐fluorophenyl)‐2‐[(propan‐2‐yl)amino]pentan‐1‐one | F-NPP | C14H20FNO | 237.31 | 114 | 72 | 30 | 4.04 | show | OWNVSTVTZITAOJ-UHFFFAOYSA-N | test purchase | Purchased as NPP; compound is not pure by NMR-inpurity cca 25% - (possibly isopropyl amine) | 2015-10-04 | 2015-12-12 | RESPONSE project; 2015-2017 | 1284-15 | |
Cannabinoids | FUB-PB22 | 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 8-quinolinyl ester | C25H17FN2O2 | 396.41 | 109 | 252 | 253 | 18.92 | show | ROHVURVXAOMRJY-UHFFFAOYSA-N | test purchase | purchased as FDU-PB22 | 2015-10-04 | 2015-12-12 | RESPONSE project; 2015-2017 | 1286-15 | ||
Benzodiazepines | CLONAZOLAM | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-s-triazolo(4,3-a)-(1,4)-benzodiazepine | clontrazolam | C17H12ClN5O2 | 353.77 | 324 | 203 | 249 | 15.71 | show | XJRGLCAWBRZUFC-UHFFFAOYSA-N | test purchase | 2015-10-04 | 2015-12-12 | RESPONSE project; 2015-2017 | 1282-15 | ||
Benzodiazepines | Flubromazepam | 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C15H10BrFN2O | 333.15 | 304 | 303 | 305 | 9.99 | show | ZRKDDZBVSZLOFS-UHFFFAOYSA-N | test purchase | 2015-10-05 | RESPONSE project; 2015-2017 | 1192-15 | ||||
Others | Phenetrazine | 3‐ethyl‐2‐phenylmorpholine | C12H17NO | 191.27 | 56 | 85 | 70 | 3.99 | show | DOMAVIHZFHQQHF-UHFFFAOYSA-N | test purchase | 2015-10-14 | 2015-12-12 | RESPONSE project; 2015-2017 | 1289-15 | |||
Others | 3F-Phenetrazine | 3-ethyl-2-(3-fluorophenyl)morpholine | C12H16FNO | 209.26 | 56 | 85 | 70 | 3.96 | show | GPTHUZORYIVVNJ-UHFFFAOYSA-N | test purchase | 2015-10-14 | 2016-10-25 | RESPONSE project; 2015-2017 | 1292-15 | |||
Others | N-ethylphenmetrazol(NMR-ok;final report pending) | 4‐ethyl‐3‐methyl‐2‐phenylmorpholin‐2‐ol | C13H19NO2 | 221.30 | 116 | 56 | 77 | 5.36 | show | KUUJFIZDDLCPNF-UHFFFAOYSA-N | test purchase | small additional peak with the same exact mass -posibly isomeric form of the same compound (by HPLC TOF), isomeric form detected by NMR as well; GC-MS-FTIR (two peaks) infers on open and closed form of substance | 2015-10-14 | 2015-12-10 | RESPONSE project; 2015-2017 | 1290-15 | ||
Others | Isophenmetrazine | 5-methyl-2-phenylmorpholine | C11H15NO | 177.25 | 104 | 147 | 105 | 3.63 | show | LQHGEOIBMBXJGV-UHFFFAOYSA-N | test purchase | 2015-10-14 | RESPONSE project; 2015-2017 | 1293-15 | ||||
Others | 4-MPH_(Mephenmetrazine) | 3-methyl-2(p-tolyl)morpholine | 3-methyl-2-(4-methylphenyl)morpholine, 4-MPM, mephenmetrazine, 4-methylphenmetrazine | C12H17NO | 191.27 | 71 | 42 | 56 | 4.14 | show | NWNCIXFIIDVRKE-UHFFFAOYSA-N | test purchase | source II | 2015-10-14 | RESPONSE project; 2015-2017 | 1294-15 | ||
Others | 2-MeO-diphenidine | 1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidine | Methoxphenidine, MXP | C20H25NO | 295.42 | 204 | 188 | 91 | 8.25 | show | QXXCUXIRBHSITD-UHFFFAOYSA-N | test purchase | 2015-10-14 | RESPONSE project; 2015-2017 | 1195-15 | |||
Cannabinoids | MDMB-CHMICA | methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate; | N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-valine, methyl ester; methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate (stereochemistry defined) | C23H32N2O3 | 384.50 | 240 | 144 | 241 | 13.79 | show | SRJKCVHWIDFUBO-UHFFFAOYSA-N | test purchase | purchased as MMB- CHMINACA; few % of unidentified organic compound by NMR; 2017 - minor corrections of entry and report (see report) | 2015-10-14 | 2017-05-18 | RESPONSE project; 2015-2017 | 1190-15 | |
Piperidines & pyrrolidines | Propylphenidate | Propyl-2-phenyl-2-(piperidin-2-yl)acetate | 2-(2-oxo-1-phenyl-2-propoxyethyl)piperidin | C16H23NO2 | 261.37 | 84 | 91 | 56 | 6.41 | show | PRMWWEANNQSWAR-UHFFFAOYSA-N | test purchase | 2015-10-20 | RESPONSE project; 2015-2017 | 1246-15 | |||
Cathinones | NEB-Inden-Analog_(bk-IBP) | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-one | N-ethylbuphedrone-indene-analogue; bk-iBP, bk-EABDI | C15H21NO | 231.33 | 86 | 115 | 58 | 6.29 | show | VJXZPPKMTRTYIH-UHFFFAOYSA-N | test purchase | purchased as bk-IVP | 2015-10-20 | RESPONSE project; 2015-2017 | 1247-15 | ||
Benzodiazepines | Pyrazolam | 12-bromo-3-methyl-9-(pyridin-2-yl)-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(14),3,5,8,10,12-hexaene | 1-methyl[1,2,4]triazo-6-(2-pyridinyl)-8-bromo-1,4-benzodiazepine | C16H12BrN5 | 354.21 | 274 | 353 | 355 | 13.61 | show | BGRWSFIQQPVEML-UHFFFAOYSA-N | test purchase | comfirmed by HPLC-TOF and GC-MS | 2015-10-25 | RESPONSE project; 2015-2017 | 1355-15 | ||
Aminoindanes | N-Methyl-2AI | N-methyl-2,3-dihydro-1H-inden-2-amine | NM-2AI, N-methyl-2-aminoindane | C10H13N | 147.22 | 147 | 42 | 106 | 2.73 | show | SXWZQUCTTOBHJT-UHFFFAOYSA-N | test purchase | 2015-10-25 | 2015-12-03 | RESPONSE project; 2015-2017 | 1349-15 | ||
Indolalkylamines (fe tryptamines) | 1P-LSD | N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide | C23H29N3O2 | 379.22 | 379 | 277 | 221 | 17.72 | show | JSMQOVGXBIDBIE-UHFFFAOYSA-N | test purchase | 2015-10-28 | RESPONSE project; 2015-2017 | 1322-15 | ||||
Cathinones | 4F-PBP | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-butanone | C14H18FNO | 235.30 | 112 | 95 | 113 | 4.93 | show | BYMOJFLMEMTDDX-UHFFFAOYSA-N | collected | 2015-11-05 | SPL Portugal,analytically confirmed sample; see: http://www.sciencedirect.com/science/article/pii/S0379073815001942 | 1295-15 | ||||
Cannabinoids | 5F-PY-PINACA | [1-(5-fluoropentyl)indazol-3-yl]-pyrrolidin-1-yl-methanone | C17H22FN3O | 303.37 | 70 | 131 | 145 | 10.41 | show | GSCLIRQNUBFUJA-UHFFFAOYSA-N | collected | 2015-11-05 | 2015-01-06 | Swedish National Forensic Centre (NMR confirmed sample) | 1258-15 | |||
Cannabinoids | EMB-FUBINACA | Ethyl 2-[[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methyl-butanoate | Ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate | C22H24FN3O3 | 397.44 | 253 | 109 | 324 | 12.02 | show | YOECWCNJGHHTMN-UHFFFAOYSA-N | collected | 2015-11-05 | Swedish National Forensic Centre (NMR confirmed sample) | 1257-15 | |||
Cannabinoids | 5F-EMB-PINACA | Ethyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methyl-butanoate | C20H28FN3O3 | 377.46 | 233 | 304 | 145 | 10.79 | show | YWSYUMWEKPNAHT-UHFFFAOYSA-N | collected | 2015-11-05 | Swedish National Forensic Centre (NMR confirmed sample) | 1256-15 | ||||
Cathinones | 4F-PHP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | C16H22FNO | 263.40 | 140 | 141 | 95 | 6.04 | show | BCJXLSGKMNRRKO-UHFFFAOYSA-N | test purchase | Mixture with unidentified organic compound - see Analytical report | 2015-11-06 | 2016-12-08 | RESPONSE project; 2015-2017 | 1302-15 | ||
Cannabinoids | THJ-018 | 3‐(naphthalene‐1‐carbonyl)‐1‐pentyl‐1H‐indazole | naphthalen-1yl-(1-pentyl-1H-indazol-3-yl)-methanone; JWH 018 indazole analog | C23H22N2O | 342.40 | 127 | 271 | 342 | 13.04 | show | VAKGBPSFDNTMDJ-UHFFFAOYSA-N | test purchase | Analytical report revised15/01/2018. | 2015-11-06 | 2018-01-15 | RESPONSE project; 2015-2017 | 1298-15 | |
Others | PhenMetEtrazine-precursor | 2‐[ethyl(2‐hydroxyethyl)amino]‐1‐phenylpropan‐1‐ol | C13H21NO2 | 223.32 | 116 | 117 | 72 | 5.69 | show | PIQWNMHHXJMHFQ-UHFFFAOYSA-N | test purchase | NEW Analytical report issued 08/03/2016; Sample was purchased as Phenmetetrazine; Typing error in pdf file corrected 09/08/2016. | 2015-11-17 | 2016-08-09 | RESPONSE project; 2015-2017 | 1291-15 | ||
Cannabinoids | MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate | MO-AMB | C22H30N2O4 | 386.50 | 257 | 241 | 145 | 11.04 | show | SUEOBRAXHJBVGY-UHFFFAOYSA-N | RM-reference material | 2015-11-17 | RESPONSE project; 2015-2017 | 1366-15 | |||
Cannabinoids | LH-21 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole | C20H20Cl3N3 | 408.75 | 337 | 339 | 124 | 11.66 | show | USJFDADYVUDVAX-UHFFFAOYSA-N | RM-reference material | 2015-11-17 | 2018-05-28 | RESPONSE project; 2015-2017 | 1367-15 | |||
Cannabinoids | ADB-PINACA-isomer3 | (S)-N-(1-amino-1-oxohexan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | C19H28N4O2 | 344.50 | 215 | 300 | 145 | 12.02 | show | BIAATZFCIKCULE-HNNXBMFYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1369-15 | ||||
Cannabinoids | 5-Fluoropentyl-3-pyridinoylindole | (1-(5-fluoropentyl)-1H-indol-3-yl)(pyridin-3-yl)methanone | C19H19FN2O | 310.36 | 235 | 310 | 232 | 11.72 | show | CNMQLCYLJPWHEW-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1372-15 | ||||
Cannabinoids | SDB-005 | naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate | C23H22N2O2 | 358.40 | 215 | 145 | 216 | 14.61 | show | JBVNFKZVDLFOAY-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1361-15 | ||||
Piperidines & pyrrolidines | Diphenidine | 1-(1,2-Diphenylethyl)piperidine | C19H23N | 265.39 | 174 | 91 | 175 | 7.43 | show | JQWJJJYHVHNXJH-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1374-15 | ||||
Phenethylamines | 2C-TFM | 2,5-dimethoxy-4-(trifluoromethyl)-benzeneethanamine | 2C-CF3 | C11H14F3NO2 | 249.23 | 220 | 201 | 205 | 3.90 | show | LYXGNMLWYONZID-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1373-15 | |||
Cannabinoids | FUB-NPB-22 | quinolin-8-yl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate | 5-fluoro NIN; FUB-PB-22 indazole analog | C24H16FN3O2 | 397.40 | 109 | 253 | 254 | 17.74 | show | NYHGKZZRRCVGAU-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1359-15 | |||
Cannabinoids | ADB-PINACA-isomer-2 | N-((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | C19H28N4O2 | 344.50 | 215 | 300 | 145 | 11.64 | show | QFGOKLQWEVQXAP-BBRMVZONSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1371-15 | ||||
Cannabinoids | MDMB-FUBINACA | methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | FUB-MDMB; MDMB-Bz-F | C22H24FN3O3 | 397.40 | 109 | 253 | 341 | 11.75 | show | RFCDVEHNYDVCMU-LJQANCHMSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1364-15 | |||
Cannabinoids | 5-fluoro-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | C19H27FN4O2 | 362.50 | 233 | 318 | 145 | 11.86 | show | SOYDDJYBRCNNIT-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1363-15 | ||||
Cannabinoids | 3-CAF | naphthalen-2-yl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate | C24H15FN2O2 | 382.40 | 239 | 240 | 210 | 17.47 | show | VBZWFDNXUJTAGG-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1360-15 | ||||
Cannabinoids | AB-PINACA-N-(2-fluoropentyl)-isomer | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide | 2-fluoro AB-PINACA | C18H25FN4O2 | 348.40 | 233 | 304 | 145 | 11.00 | show | VKIBZLGSWZHFJD-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1358-15 | |||
Cannabinoids | FUB-JWH-018 | (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | C26H18FNO | 379.40 | 109 | 379 | 270 | 17.31 | show | VREQTLWJHFQLEX-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1370-15 | ||||
Phenethylamines | 4-Chloromethamphetamine | 4-chloro-N,α-dimethyl-benzeneethanamine | [1‐(4‐chlorophenyl)propan‐2‐yl](methyl)amine; p-CMA; Ro 4-6861; 4-CMA | C10H14ClN | 183.68 | 58 | 125 | 56 | 3.13 | show | XXLWNLKEOWWHDC-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1365-15 | |||
Phenethylamines | 2-Bromo-4,5-MDMA | 1-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-methylpropan-2-amine | 6-bromo MDMA; 2-bromo-4,5-Methylenedioxymethamphetamine | C11H14BrNO2 | 272.14 | 58 | 56 | 75 | 5.73 | show | ZIBHSZQEEWBQLW-UHFFFAOYSA-N | RM-reference material | 2015-11-18 | RESPONSE project; 2015-2017 | 1362-15 | |||
Aminoindanes | MDAI | 2H,5H,6H,7H-indeno[5,6-d][1,3]dioxol-6-amine | 5,6-methylenedioxy-2-aminoindane | C10H11NO2 | 177.20 | 160 | 149 | 177 | 4.31 | show | FQDRMHHCWZAXJM-UHFFFAOYSA-N | test purchase | 2015-11-25 | 2015-12-03 | RESPONSE project; 2015-2017 | 1347-15 | ||
Arylalkylamines | BK-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one | C10H12BrNO3 | 274.11 | 243 | 245 | 194 | 6.88 | show | HFYJGAIOBIDRPX-UHFFFAOYSA-N | test purchase | Confirmed by GC-MS and-HPLC TOF (MS consistent by SWGDRUG.L) | 2015-11-25 | 2015-12-03 | RESPONSE project; 2015-2017 | 1350-15 | ||
Arylalkylamines | 5-MeO-DIBF | [2-(5-methoxy-1-benzofuran-3-yl)ethyl]bis(propan-2-yl)amine | C17H25NO2 | 275.39 | 114 | 72 | 115 | 7.21 | show | NBFMSQBTYHYVKP-UHFFFAOYSA-N | test purchase | 2015-11-25 | 2015-12-19 | RESPONSE project; 2015-2017 | 1353-15 | |||
Phenethylamines | DOPR | 1-(2,5-dimethoxy-4-propylphenyl)propan-2-amine | C14H23NO2 | 237.34 | 44 | 194 | 165 | 5.40 | show | UEEAUFJYLUJWQJ-UHFFFAOYSA-N | test purchase | 2015-11-25 | 2015-12-19 | RESPONSE project; 2015-2017 | 1377-15 | |||
Arylcyclohexylamines | 4-methoxy-PCP | 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine | 4-MeO Phencyclidine; Methoxydine; 4-MeO PCP | C18H27NO | 273.41 | 121 | 230 | 189 | 8.08 | show | MUZGGFNYVLGUFS-UHFFFAOYSA-N | RM-reference material | 2015-11-27 | RESPONSE project; 2015-2017 | 1356-15 | |||
Cannabinoids | AB-FUBINACA-2-fluorobenzyl-isomer | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxamide | C20H21FN4O2 | 368.40 | 253 | 109 | 324 | 13.14 | show | AJGUHANHCUPXSK-KRWDZBQOSA-N | RM-reference material | 2015-12-03 | RESPONSE project; 2015-2017 | 1368-15 | ||||
Cannabinoids | ADB-PINACA-isomer-1 | N-(1-amino-2,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | C19H28N4O2 | 344.50 | 215 | 300 | 145 | 11.33 | show | WLFSZTSBEOZUTQ-UHFFFAOYSA-N | RM-reference material | 2015-12-03 | RESPONSE project; 2015-2017 | 1357-15 | ||||
Cannabinoids | BB-22 | quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate | QUCHIC | C25H24N2O2 | 384.47 | 240 | 144 | 241 | 19.38 | show | RHYGTJXOHOGQGI-UHFFFAOYSA-N | test purchase | 2015-12-14 | RESPONSE project; 2015-2017 | 1299-15 | |||
Cathinones | tBuONE | 1‐(2H‐1,3‐benzodioxol‐5‐yl)‐2‐(tert‐butylamino)propan‐1‐one | MDPT | C14H19NO3 | 249.31 | 44 | 100 | 149 | 5.93 | show | BFOZYEAQPUMNIY-UHFFFAOYSA-N | test purchase | Sample was purchased as 5-Methyl-Ethylone | 2015-12-16 | RESPONSE project; 2015-2017 | 1378-15 | ||
Cannabinoids | EG-018 | 3‐(naphthalene‐1‐carbonyl)‐9‐pentyl‐9H‐carbazole | C28H25NO | 391.20 | 334 | 391 | 127 | 20.61 | show | FJMMDJDPNLZYLA-UHFFFAOYSA-N | test purchase | Purchased as EG-2201 (and another one, of the same chemical characteristic as EG-018 ) | 2015-12-16 | RESPONSE project; 2015-2017 | 1379-15 | |||
Others | CRL-40941 | 2-[bis(4-fluorophenyl)methylsulfinyl]-N-hydroxyacetamide | Fladrafinil, Fluorafinil | C15H13F2NO3S | 325.33 | 203 | 183 | 201 | 9.78 | show | VKGUUSVYPXTWMA-UHFFFAOYSA-N | test purchase | impurities (see Analytical report); report corrected 21/012/2016 | 2015-12-16 | 2016-02-21 | RESPONSE project; 2015-2017 | 1321-15 | |
Piperidines & pyrrolidines | 4F-MPH | methyl 2-(4-fluorophenyl)-2-(2-piperidyl)acetate | 4-fluoromethylphenidate | C14H18FNO2 | 251.30 | 84 | 109 | 56 | 5.30 | show | XISBAJBPDVRSPG-UHFFFAOYSA-N | test purchase | At least two isomers + impurity | 2015-12-16 | 2016-01-04 | RESPONSE project; 2015-2017 | 1352-15 | |
Phenethylamines | 25C-NBF | [2-(4-chloro-2,5-dimethoxyphenyl)ethyl][(2-fluorophenyl)methyl]amine | C17H19ClFNO2 | 323.79 | 109 | 138 | 186 | 9.11 | show | AHIUIEOLKNDLSC-UHFFFAOYSA-N | test purchase | 2015-12-18 | 2016-02-22 | RESPONSE project; 2015-2017 | 1385-15 | |||
Cannabinoids | FUB-AMB | methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate | methyl(1-(4-fluorobenzyl)-1H- indazole-3-carbonyl)-L-valinate; AMB-FUBINACA | C21H22FN3O3 | 383.42 | 109 | 253 | 324 | 11.57 | show | FRFFLYJQPCIIQB-SFHVURJKSA-N | test purchase | 2015-12-18 | RESPONSE project; 2015-2017 | 1387-15 | |||
Cathinones | 4-MDMC | 2‐(dimethylamino)‐1‐(4‐methylphenyl)propan‐1‐one | 4-Methyl-N,N-dimethylcathinone; | C12H17NO | 191.27 | 72 | 91 | 42 | 3.74 | show | FXLSIGLYVVJURY-UHFFFAOYSA-N | test purchase | Purchased as2-NMC (N,2-dimethyl-N-(4-methylphenyl)propanamide) | 2015-12-18 | 2015-01-15 | RESPONSE project; 2015-2017 | 1382-15 | |
Opioids | FU-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide | C24H26N2O2 | 374.48 | 283 | 95 | 240 | 13.70 | show | FZJVHWISUGFFQV-UHFFFAOYSA-N | test purchase | Substantial amount of Furancarboxylic acid detected by GC-MS, sample is not pure by NMR | 2015-12-18 | 2015-01-26 | RESPONSE project; 2015-2017 | 1394-15 | ||
Cannabinoids | SDB-005 | naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate | C23H22N2O2 | 358.44 | 215 | 145 | 216 | 14.61 | show | JBVNFKZVDLFOAY-UHFFFAOYSA-N | test purchase | Confirmed by reference material ID 1361-15 | 2015-12-18 | 2015-01-26 | RESPONSE project; 2015-2017 | 1389-15 | ||
Opioids | U-47700 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide | C16H22Cl2N2O | 329.27 | 84 | 125 | 71 | 9.46 | show | JGPNMZWFVRQNGU-UHFFFAOYSA-N | test purchase | Impurity detected by NMR | 2015-12-18 | 2016-01-26 | RESPONSE project; 2015-2017 | 1381-15 | ||
Cathinones | BK-IVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-one | C16H23NO | 245.37 | 100 | 115 | 58 | 6.74 | show | JKHIJQTXTPXKTI-UHFFFAOYSA-N | test purchase | 2015-12-18 | 2016-01-22 | RESPONSE project; 2015-2017 | 1384-15 | |||
Cathinones | 4-Cl-PPP | 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)propan-1-one | C13H16ClNO | 237.73 | 98 | 56 | 99 | 5.84 | show | ULRSISQFKHWZNP-UHFFFAOYSA-N | test purchase | 2015-12-18 | 2016-01-15 | RESPONSE project; 2015-2017 | 1392-15 | |||
Cathinones | Dibutylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)butan-1-one | methylbutylone, m-butylone, N-methylbutylone, butylone ME, bk-dMBDB | C13H17NO3 | 235.28 | 86 | 71 | 87 | 5.87 | show | USEBIPUIVPERGC-UHFFFAOYSA-N | test purchase | 2015-12-18 | RESPONSE project; 2015-2017 | 1395-15 | |||
Cathinones | BK-Ethyl-K | 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one | Ephylone, N-ethyl-norpentylone, N-ethyl-pentylone, bk-EBDP, βk-Ethyl-K, βk-EBDP, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone | C14H19NO3 | 249.31 | 100 | 58 | 101 | 6.47 | show | VERDHJIMZYXGIW-UHFFFAOYSA-N | test purchase | 2015-12-18 | 2016-01-15 | RESPONSE project; 2015-2017 | 1390-15 | ||
Cannabinoids | 5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | C20H28FN3O2 | 361.45 | 232 | 144 | 233 | 13.49 | show | ITZSOCZDFSHNCL-UHFFFAOYSA-N | RM-reference material | 2016-01-05 | RESPONSE project; 2015-2017 | 1417-15 | ||||
Others | Mebroqualone | 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | C15H11BrN2O | 315.16 | 235 | 236 | 76 | 8.99 | show | NBUSAPJNASSKBP-UHFFFAOYSA-N | RM-reference material | 2016-01-05 | RESPONSE project; 2015-2017 | 1415-15 | ||||
Phenethylamines | DOF | 2,5-Dimethoxy-4-fluoroamphetamine | C11H16FNO2 | 213.25 | 44 | 170 | 155 | 4.04 | show | NRANUECGGQVXOT-UHFFFAOYSA-N | RM-reference material | 2016-01-05 | RESPONSE project; 2015-2017 | 1413-15 | ||||
Piperidines & pyrrolidines | N-(2,6-dimethylphenyl)-1-piperidineacetamide | N-(2,6-Dimethylphenyl)-1-piperidineacetamide | C15H22N2O | 246.35 | 98 | 84 | 99 | 7.58 | show | OVECJQXXUIVZBI-UHFFFAOYSA-N | RM-reference material | 2016-01-05 | RESPONSE project; 2015-2017 | 1414-15 | ||||
Cannabinoids | 5F-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | C19H27FN4O2 | 362.44 | 233 | 318 | 145 | 11.79 | show | SOYDDJYBRCNNIT-UHFFFAOYSA-N | RM-reference material | 2016-01-05 | RESPONSE project; 2015-2017 | 1416-15 | ||||
Cathinones | 2,3-DMMC | 1-(2,3-dimethylphenyl)-2-(methylamino)propan-1-one | C12H17NO | 191.27 | 58 | 77 | 56 | 3.94 | show | APVRHNHXZXFDLN-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1427-15 | ||||
Cannabinoids | AM-2201-4-methoxynaphthyl-analogue | 1-(5-fluoropentyl)-3-(4-methoxynaphthalene-1-carbonyl)-1H-indole | AM-2201 4-methoxynaphthyl metabolite | C25H24FNO2 | 389.47 | 389 | 314 | 185 | 18.16 | show | BIESBZORWYRYDT-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1426-15 | |||
NPS-related (building blocks) | 1-Cyclohexylmethylindole | 1‐(cyclohexylmethyl)‐1H‐indole | C15H19N | 213.32 | 130 | 213 | 131 | 6.36 | show | HIOJKWCIURECFH-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1424-15 | ||||
Cannabinoids | ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide | C20H29N3O2 | 343.46 | 214 | 144 | 215 | 12.56 | show | IXUYMXAKKYWKRG-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1418-15 | ||||
Others | 4-Fluorococaine | methyl (1R,2R,3S,5S)-3-(4-fluorobenzoyloxy)-8-methyl-8-azabicyclo[3.2.1] octane-2-carboxylate | C17H20FNO4 | 321.34 | 82 | 182 | 94 | 8.04 | show | JRPRINGETIYVSV-LJISPDSOSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1421-15 | ||||
Phenethylamines | N-Me-2C-H | 2,5-Dimethoxy-N-methylphenethylamine | C11H17NO2 | 195.26 | 44 | 152 | 137 | 4.25 | show | PIGIFXLLTQEIPK-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1428-15 | ||||
NPS-related (building blocks) | 1-Pentylindole | 1-pentyl-1H-indole | 1H-indole, 1-pentyl- | C13H17N | 187.28 | 130 | 187 | 131 | 4.52 | show | QWLCOOAYMQWDPR-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1425-15 | |||
Cannabinoids | MN-18 | N-(naphthalen-1-yl)-1-pentyl-1H-indazol-3-carboxamide | C23H23N3O | 357.45 | 215 | 145 | 357 | 16.62 | show | UJKHLVOEXULDRU-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1419-15 | ||||
Cannabinoids | NPB-22 | 1-pentyl-1H-indazole-3-carboxylic acid, 8-quinolinyl ester | 1-pentyl-1H-indazole-3-carboxylic acid, 8-quinolinyl ester; PB-22 indazole analogue | C22H21N3O2 | 359.43 | 215 | 145 | 216 | 15.25 | show | UWICFJAXLKCHTQ-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1423-15 | |||
Piperidines & pyrrolidines | FLUOROLINTANE | 1-(1-(2-fluorophenyl)-2-phenylethyl)pyrrolidine | 2-FPPP | C18H20FN | 269.36 | 178 | 109 | 179 | 6.75 | show | ZAGWVXYVNFPCLW-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1420-15 | |||
Indolalkylamines (fe tryptamines) | DIPT | N,N-Diisopropyltryptamine | C16H24N2 | 244.38 | 114 | 72 | 130 | 7.42 | show | ZRVAAGAZUWXRIP-UHFFFAOYSA-N | RM-reference material | 2016-01-06 | RESPONSE project; 2015-2017 | 1422-15 | ||||
Arylcyclohexylamines | 3-MeO-PCMo | 4‐[1‐(3‐methoxyphenyl)cyclohexyl]morpholine | C17H25NO2 | 275.39 | 232 | 121 | 275 | 8.17 | show | BOGOEDFWPOXWQE-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1431-16 | ||||
Opioids | AH-7921 | 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide | C16H22Cl2N2O | 329.27 | 126 | 127 | 173 | 10.31 | show | JMZROFPPEXCTST-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1434-16 | ||||
Cathinones | 4F-PV9 | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)octan-1-one | 4'-Fluoro-α-pyrrolidinooctanophenone; 4-Fluoro-PV-9, FPOP, 4-Fluoro-α-POP | C18H26FNO | 291.41 | 168 | 169 | 123 | 7.24 | show | MNXIGHJMEAJIEV-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1433-16 | |||
Cathinones | 4-MeO-PV9 | 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one | C19H29NO2 | 303.22 | 168 | 169 | 135 | 8.86 | show | TVTBLEFOUUDRBK-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1436-16 | ||||
Cathinones | N-Ethyl-norpentylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one | Ephylone, BK-Ethyl-K, N-ethyl-pentylone, bk-EBDP, βk-Ethyl-K, βk-EBDP, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone | C14H19NO3 | 249.31 | 100 | 58 | 101 | 6.46 | show | VERDHJIMZYXGIW-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1437-16 | |||
Opioids | W-15 | 4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide | C19H21ClN2O2S | 376.90 | 207 | 104 | 111 | 15.84 | show | VJHXSSVOCOBVMI-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1435-16 | ||||
Cathinones | 4F-PV8 | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)heptan-1-one | C17H24FNO | 277.38 | 154 | 155 | 95 | 6.65 | show | YAFFHHPPOAYLLA-UHFFFAOYSA-N | collected | 2016-01-15 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1432-16 | ||||
Cannabinoids | AM-2201 | 1‐(5‐fluoropentyl)‐3‐(naphthalene‐1‐carbonyl)‐1H‐indole | C24H22FNO | 359.44 | 359 | 232 | 284 | 15.86 | show | ALQFAGFPQCBPED-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1478-16 | ||||
Aminoindanes | 5-IAI | 5-Iodo-2,3-dihydro-1H-inden-2-amine | 5-Iodo-2-aminoindane | C9H10IN | 259.09 | 259 | 115 | 117 | 4.86 | show | BIHPYCDDPGNWQO-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1475-16 | |||
Arylcyclohexylamines | 3-MeO-PCP | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | 3-Methoxyphencyclidine | C18H27NO | 273.42 | 230 | 272 | 273 | 7.89 | show | BQQSZHHKGPOXLN-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1468-16 | |||
Aminoindanes | 2-AI | 2,3-dihydro-1H-inden-2-ylamine | 2-Aminoindane | C9H11N | 133.19 | 133 | 116 | 91 | 2.55 | show | LMHHFZAXSANGGM-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1469-16 | |||
Arylcyclohexylamines | 4-MeO-PCP | 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine | 4-Methoxyphencyclidine | C18H27NO | 273.42 | 121 | 230 | 189 | 8.12 | show | MUZGGFNYVLGUFS-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1472-16 | |||
Cannabinoids | JWH-081 | (1-pentyl-3-(4-methoxy-1-naphthoyl)indole) | ((4-Methoxynaphthalen-1-yl)(1-pentylindol-3-yl)methanone) | C25H25NO2 | 371.47 | 371 | 214 | 314 | 17.23 | show | UBMPKJKGUQDHRM-UHFFFAOYSA-N | RM-reference material | 2016-01-20 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1488-16 | |||
Indolalkylamines (fe tryptamines) | 2-(1H-indol-3-yl)-N,N-dipropylacetamide | 2-(1H-indol-3-yl)-N,N-dipropylacetamide | C16H22N2O | 258.37 | 130 | 258 | 128 | 9.00 | show | AEPJTCZBIULDTE-UHFFFAOYSA-N | collected | 2016-02-10 | Joined report: I-SEE and RESPONSE projects | 1504-16 | ||||
Cathinones | N-ethylhexedrone | 2-(ethylamino)-1-phenylhexan-1-one | Ethyl-hexedrone, HEXEN, HEX EN, NEH | C14H21NO | 219.33 | 114 | 58 | 77 | 4.65 | show | CWNKMHIETKEBCA-UHFFFAOYSA-N | collected | Joined report: I-SEE and RESPONSE projects | 2016-02-10 | RESPONSE project; 2015-2017 | 1503-16 | ||
Cathinones | Mexedrone | 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | MEX, 4-MMC-oMe, | C12H17NO2 | 207.27 | 88 | 56 | 91 | 4.54 | show | JHGDCSPZKQLBOP-UHFFFAOYSA-N | collected | 2016-02-10 | Joined report: I-SEE and RESPONSE projects; organic impurities detected by GC-MS | 1519-16 | |||
Others | PDM-35 | 2-phenyl-3,5-dimethylmorpholine | 5-Methylphenmetrazine | C12H17NO | 191.27 | 70 | 85 | 44 | 3.75 | show | YKCSYIYQRSVLAK-UHFFFAOYSA-N | test purchase | HPLC TOF and GC-MS two major peaks for C12H17NO and same mass spectra; NMR: a mixture of two very similar compounds (probably diastereoisomers) in approx. molar ratio 3:2 | 2016-02-10 | RESPONSE project; 2015-2017 | 1408-16 | ||
Piperidines & pyrrolidines | HDMP-28 | methyl 2-(2-naphthyl)-2-(2-piperidyl)acetate | methylnaphthidate | C18H21NO2 | 283.36 | 180 | 200 | 181 | 9.40 | show | DNRNSIJBSCBESJ-UHFFFAOYSA-N | test purchase | Nonderivatized sample decomposes in GC. RT and MS spectrum refer to TFA derivative | 2016-02-11 | RESPONSE project; 2015-2017 | 1409-16 | ||
Phenethylamines | Allylescaline | 4-allyloxy-3,5-dimethoxy-phenethylamine | 2-[3,5-Dimethoxy-4-(prop-2-en-1-yloxy)phenyl]ethanamine | C13H19NO3 | 237.30 | 167 | 168 | 237 | 5.82 | show | JNUAYHHGCXYBHX-UHFFFAOYSA-N | test purchase | 2016-02-11 | RESPONSE project; 2015-2017 | 1406-16 | |||
Phenethylamines | Escaline | 2-(4-Ethoxy-3,5-dimethoxyphenyl)ethanamine | 4-ethoxy mescaline | C12H19NO3 | 225.28 | 167 | 196 | 168 | 5.29 | show | RHOGRSKNWDNCDN-UHFFFAOYSA-N | test purchase | 2016-02-11 | RESPONSE project; 2015-2017 | 1407-16 | |||
Cannabinoids | ADB-CHMINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | MAB-CHMINACA | C21H30N4O2 | 370.50 | 241 | 326 | 145 | 13.51 | show | ZWCCSIUBHCZKOY-UHFFFAOYSA-N | test purchase | Not pure; purchased as 5F-AEB | 2016-02-11 | RESPONSE project; 2015-2017 | 1380-15 | ||
Cathinones | 4-CIC | 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one | C12H16ClNO | 225.72 | 86 | 44 | 111 | 4.43 | show | AZTFYJYLDIQSAG-UHFFFAOYSA-N | test purchase | 2016-02-12 | 2016-02-22 | RESPONSE project; 2015-2017 | 1502-16 | |||
Others | Memantine | 3,5-dimethyladamantan-1-amine | C12H21N | 179.30 | 108 | 122 | 179 | 2.69 | show | BUGYDGFZZOZRHP-UHFFFAOYSA-N | test purchase | 2016-02-12 | RESPONSE project; 2015-2017 | 1410-16 | ||||
Others | 3,6-DMPM | 3,6-dimethyl-2-phenylmorpholine | 2-Phenyl-3,6-dimethylmorpholine | C12H17NO | 191.27 | 70 | 85 | 44 | 3.78 | show | FZEIVUHEODGHML-UHFFFAOYSA-N | test purchase | MS, TOF: two signals - diastereoisomers, NMR: 3 isomers | 2016-02-12 | 2016-02-19 | RESPONSE project; 2015-2017 | 1412-16 | |
Cannabinoids | AKB-57 | adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate | AKB57 | C23H30N2O2 | 366.31 | 135 | 231 | 215 | 13.31 | show | KCCVWUAAHDXNNQ-UHFFFAOYSA-N | test purchase | Another sample, which was purchased as 5F-AKB57 contained AKB57 as well | 2016-02-12 | RESPONSE project; 2015-2017 | 1521-16 | ||
Cathinones | 4-CEC | 1-(4-chlorophenyl)-2-(ethylamino)propan-1-one | 4-chloroethcathinone | C11H14ClNO | 211.69 | 72 | 44 | 111 | 4.26 | show | RNBCGEIZCHBTGL-UHFFFAOYSA-N | test purchase | 2016-02-12 | 2016-02-28 | RESPONSE project; 2015-2017 | 1501-16 | ||
Others | VX-809 | 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | Lumacaftor | C24H18F2N2O5 | 452.41 | 496 | 497 | 495 | 16.05 | show | UFSKUSARDNFIRC-UHFFFAOYSA-N | test purchase | RT and MS spectrum refer to MSTFA derivative | 2016-02-12 | RESPONSE project; 2015-2017 | 1500-16 | ||
Indolalkylamines (fe tryptamines) | 4-AcO-DET | 3-[2-(diethylamino)ethyl]-1H-indol-4-yl acetate | 4-Acetoxy-DET | C16H22N2O2 | 274.36 | 86 | 87 | 58 | 8.58 | show | WYEVVQJLTXBMPM-UHFFFAOYSA-N | test purchase | Fumaric acid by GC-MS + cca5% of organic impurity | 2016-02-12 | 2018-05-28 | RESPONSE project; 2015-2017 | 1411-16 | |
Cathinones | 2-Fluoromethcathinone (2-FMC) | 1-(2-fluorophenyl)-2-(methylamino)propan-1-one | 2-FMC | C10H12FNO | 181.21 | 58 | 56 | 95 | 2.812 | show | DCMOUMKIDLRIBO-UHFFFAOYSA-N | RM-reference material | in GC compound partially disproportionate | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1470-16 | ||
Indolalkylamines (fe tryptamines) | 5-methoxy-DiPT | [2-(5-methoxy-1H-indol-3-yl)ethyl]bis(propan-2-yl)amine | 5-MeO DiPT; 5-methoxy-N,N-Diisopropyltryptamine; FOXY | C17H26N2O | 274.41 | 114 | 72 | 160 | 8.63 | show | DNBPMBJFRRVTSJ-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1476-16 | |||
Phenethylamines | 25I-NBOH | 2-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol | 2C-I-NBOH, NBOH-2CI, Cimbi-27 | C17H20INO3 | 413.26 | 179 | 280 | 73 | 12.04 | show | FEUZHYRXGQTBRO-UHFFFAOYSA-N | test purchase | RT and MS spectrum for di-TMS derivative (see Analytical report) | 2016-02-19 | 2016-02-19 | RESPONSE project; 2015-2017 | 1383-15 | |
Cannabinoids | CP 47,497-C8-homolog | 2-(3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol | Cannabicyclohexanol | C22H36O2 | 332.53 | 215 | 233 | 216 | 10.74 | show | HNMJDLVMIUDJNH-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1463-16 | |||
Cannabinoids | JWH-007 | 2-methyl-3-(naphthalene-1-carbonyl)-1-pentyl-1H-indole | (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone | C25H25NO | 355.48 | 355 | 354 | 127 | 15.47 | show | IBBNKINXTRKICJ-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1484-16 | |||
Indolalkylamines (fe tryptamines) | 4-hydroxy-DiPT | 3-{2-[bis(propan-2-yl)amino]ethyl}-1H-indol-4-ol | 4-OH DiPT, 4-Hydroxy-N,N-diisopropyltryptamine | C16H24N2O | 260.38 | 114 | 72 | 146 | 8.75 | show | KBRYKXCBGISXQV-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1471-16 | |||
Cannabinoids | JWH-210 | 3-(4-ethylnaphthalene-1-carbonyl)-1-pentyl-1H-indole | (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | C26H27NO | 369.51 | 369 | 214 | 352 | 16.55 | show | LACIUQLUNACUKC-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1490-16 | |||
Cannabinoids | AM-694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)-1H-indole | [1-(5-fluoropentyl)-1H-indol-3-yl](2-iodophenyl)-methanone | C20H19FINO | 435.27 | 232 | 435 | 220 | 13.70 | show | LFFIIZFINPPEMC-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1479-16 | |||
Cathinones | Ethcathinone | 2-(ethylamino)-1-phenyl-1-propanone | N-Ethylcathinone | C11H15NO | 177.25 | 72 | 44 | 77 | 3.21 | show | LYMHIBZGTAPASQ-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1483-16 | |||
Cannabinoids | JWH-019 | 1-hexyl-3-(naphthalene-1-carbonyl)-1H-indole | (1-hexyl-1H-indol-3-yl)-1-naphthalenyl-methanone | C25H25NO | 355.48 | 355 | 284 | 228 | 15.81 | show | PALJPGHWDUHUPO-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1486-16 | |||
Phenethylamines | 25D-NBOMe | [2-(2,5-dimethoxy-4-methylphenyl)ethyl][(2-methoxyphenyl)methyl]amine | NBOMe-2C-D | C19H25NO3 | 315.41 | 121 | 150 | 91 | 9.47 | show | UTVHBNXCFSATDB-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1465-16 | |||
Cannabinoids | JWH-307 | 2-(2-fluorophenyl)-4-(naphthalene-1-carbonyl)-1-pentyl-1H-pyrrole | [5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | C26H24FNO | 385.48 | 385 | 155 | 127 | 15.58 | show | WYNZPDDTQGVCLZ-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1493-16 | |||
Cannabinoids | JWH-251 | 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone | C22H25NO | 319.45 | 214 | 144 | 215 | 11.70 | show | YBIPNGRKUAVSBG-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1492-16 | |||
Phenethylamines | 2C-N | 2,5-dimethoxy-4-nitro-benzeneethanamine | 2,5-Dimethoxy-4-nitrophenethylamine; 2‐(2,5‐dimethoxy‐4‐nitrophenyl)ethan‐1‐amine | C10H14N2O4 | 226.23 | 197 | 167 | 120 | 6.738 | show | ZMUSDZGRRJGRAO-UHFFFAOYSA-N | RM-reference material | 2016-02-19 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1467-16 | |||
Phenethylamines | Homoveratrylamine | 2-(3,4-dimethoxyphenyl)ethan-1-amine | C10H15NO2 | 181.24 | 152 | 151 | 30 | 4.01 | show | ANOUKFYBOAKOIR-UHFFFAOYSA-N | RM-reference material | 2016-03-04 | RESPONSE project; 2015-2017 | 1342-16 | ||||
Phenethylamines | 4-Methyl-N-ethyl-norephedrine | 1-(4-Methylphenyl)-2-ethylamino-1-propanol | 2‐(ethylamino)‐1‐(4‐methylphenyl)propan‐1‐ol | C12H19NO | 193.29 | 72 | 44 | 91 | 4.00 | show | AQJDADTYOSUEIK-UHFFFAOYSA-N | RM-reference material | 2016-03-04 | RESPONSE project; 2015-2017 | 1345-16 | |||
Phenethylamines | HMA | 4-(2-aminopropyl)-2-methoxyphenol | 4-hydroxy-3-methoxyamphetamine | C10H15NO2 | 181.24 | 44 | 138 | 137 | 4.01 | show | GPBOYXOSSQEJBH-UHFFFAOYSA-N | RM-reference material | 2016-03-04 | RESPONSE project; 2015-2017 | 1344-16 | |||
Phenethylamines | 4-Ethylephedrine | 1-(4-ethylphenyl)-2-(methylamino)propan-1-ol | C12H19NO | 193.29 | 58 | 91 | 56 | 4.24 | show | MMTHSVQWQJSUJY-UHFFFAOYSA-N | RM-reference material | 2016-03-04 | RESPONSE project; 2015-2017 | 1343-16 | ||||
Cathinones | Propylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one | bk-3,4-MDPA, 3,4-methylenedioxy-N-propylcathinone, Propylone | C13H17NO3 | 235.28 | 86 | 44 | 65 | show | YFVKHKCZBSGZPE-UHFFFAOYSA-N | analytical report | 2016-03-04 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-16020009 | ||||
Piperazine derivates | DBZP | 1,4-bis(phenylmethyl)-piperazine | DBZP, 1,4-Dibenzylpiperazine | C18H22N2 | 266.39 | 91 | 175 | 120 | 8.08 | show | YPUGLZQRXQQCSX-UHFFFAOYSA-N | RM-reference material | 2016-03-04 | RESPONSE project; 2015-2017 | 1341-16 | |||
Phenethylamines | 2C-T-4-NBOMe | {2-[2,5-dimethoxy-4-(propan-2-ylsulfanyl)phenyl]ethyl}[(2-methoxyphenyl)methyl]amine | 25T4-NB2OMe | C21H29NO3S | 375.53 | 121 | 150 | 91 | 11.38 | show | BOWHVFJVXBVJCU-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | RESPONSE project; 2015-2017 | 1335-16 | |||
Phenethylamines | 2C-T-7-NBOMe | {2-[2,5-dimethoxy-4-(propylsulfanyl)phenyl]ethyl}[(2-methoxyphenyl)methyl]amine | 25T7-NB2OMe | C21H29NO3S | 375.53 | 121 | 150 | 91 | 11.89 | show | CPVMNHOHOSNFOP-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | RESPONSE project; 2015-2017 | 1336-16 | |||
Cannabinoids | UR-144 | 1-pentyl-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | KM X-1, TMCP-018, MN-001, YX-17 | C21H29NO | 311.47 | 214 | 144 | 296 | 9.71 | show | NBMMIBNZVQFQEO-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | RESPONSE project; 2015-2017 | 1339-16 | |||
Phenethylamines | 2C-T-2-NBOMe | {2-[4-(ethylsulfanyl)-2,5-dimethoxyphenyl]ethyl}[(2-methoxyphenyl)methyl]amine | 25T2-NB2OMe | C20H27NO3S | 361.50 | 121 | 150 | 91 | 11.36 | show | OZEBFZPAWCXEGK-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | RESPONSE project; 2015-2017 | 1334-16 | |||
Phenethylamines | 2C-P-NBOMe | [2-(2,5-dimethoxy-4-propylphenyl)ethyl][(2-methoxyphenyl)methyl]amine | 25P-NB2OMe; 2-(4-Propyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | C21H29NO3 | 343.46 | 121 | 150 | 91 | 10.09 | show | QHEBYIJRKGDFGH-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | 2018-05-28 | RESPONSE project; 2015-2017 | 1333-16 | ||
Cathinones | 3,4-methylenedioxy-N-propylcathinone_(Propylone) | 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one | bk-3,4-MDPA, 3,4-methylenedioxy-N-propylcathinone, Propylone | C13H17NO3 | 235.28 | 86 | 65 | 149 | 6.13 | show | YFVKHKCZBSGZPE-UHFFFAOYSA-N | collected | 2016-03-08 | Institute of forensic medicine, University of Freiburg, Germany (not identified sample). | 1446-16 | |||
Cannabinoids | PB-22 | quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate | QUPIC | C23H22N2O2 | 358.44 | 214 | 144 | 215 | 16.38 | show | ZAVGICCEAOUWFM-UHFFFAOYSA-N | RM-reference material | 2016-03-08 | RESPONSE project; 2015-2017 | 1338-16 | |||
Cannabinoids | LTI-701 | 1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide | C20H21FN2O | 324.40 | 232 | 144 | 233 | 14.01 | show | FZYJALPWLNXEIP-UHFFFAOYSA-N | collected | 2016-03-09 | Sample was kindly provided by Institute of forensic medicine, University of Freiburg, Germany. | 1458-16 | ||||
Cannabinoids | AMB | methyl 3-methyl-2-[(1-pentyl-1H-indazol-3-yl)formamido]butanoate | AMP; methyl (1-pentyl-1H-indazole-3-carbonyl)-valinate | C19H27N3O3 | 345.44 | 215 | 286 | 145 | 9.97 | show | KTTMFFHXDMTTOB-UHFFFAOYSA-N | collected | 2016-03-09 | Sample was kindly provided by Institute of forensic medicine, University of Freiburg, Germany. | 1462-16 | |||
Phenethylamines | 25I-NBF | N-(2-fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine | 25I-NB2F, 2C-I-NBF, NBF-2C-I, Cimbi-21 | C17H19FINO2 | 415.24 | 109 | 138 | 278 | 10.11 | show | LPBKNBHMWRBPHT-UHFFFAOYSA-N | test purchase | Non soluble impurities - not identified | 2016-03-09 | 2018-04-13 | RESPONSE project; 2015-2017 | 1386-15 | |
Others | Phenmetetrazine | 4-ethyl-3-methyl-2-phenylmorpholine | C13H19NO | 205.30 | 56 | 71 | 99 | 4.23 | show | ZOMTUQAEMGCZPK-UHFFFAOYSA-N | synthesized | 2016-03-09 | RESPONSE project; 2015-2017 | 1291-15S | ||||
Cannabinoids | XLR-11 | 1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | 5-fluoro UR-144, 5-FUR-144 | C21H28FNO | 329.46 | 232 | 144 | 314 | 10.21 | show | PXLDPUUMIHVLEC-UHFFFAOYSA-N | RM-reference material | 2016-03-10 | RESPONSE project; 2015-2017 | 1340-16 | |||
Cathinones | Ethcathinone | 2-(ethylamino)-1-phenylpropan-1-one | N-ethylaminopropiophenone | C11H15NO | 177.25 | 72 | 44 | 77 | 3.18 | show | LYMHIBZGTAPASQ-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1325-16 | |||
Cathinones | Methedrone | 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one | para-Methoxymethcathinone; PMMC;Methoxyphedrine; 4-Methedrone, bk-PMMA | C11H15NO2 | 193.24 | 58 | 135 | 77 | 4.55 | show | MQUIHBQDYYAEMH-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1326-16 | |||
Cathinones | MDPPP | 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one | 3′,4′-Methylenedioxy-α-pyrrolidinopropiophenone | C14H17NO3 | 247.29 | 98 | 56 | 99 | 7.12 | show | NIYQOTCYXGXMPI-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1331-16 | |||
Cathinones | MPBP | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one | F 1938; 4-methyl PBP | C15H21NO | 231.34 | 112 | 113 | 91 | 5.93 | show | NXNPGAAZKYDOPW-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1327-16 | |||
Cathinones | MDPBP | 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | 3′,4′-Methylenedioxy-α-pyrrolidinobutiophenone | C15H19NO3 | 261.32 | 112 | 113 | 149 | 7.49 | show | OLVLMDVPMCIBQW-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1330-16 | |||
Cathinones | Cathinone | 2-amino-1-phenylpropan-1-one | a-Aminopropiophenone | C9H11NO | 149.13 | 44 | 77 | 51 | 2.77 | show | PUAQLLVFLMYYJJ-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1324-16 | |||
Cathinones | 3,4-MDPV | 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | 3,4-methylenedioxy pyrovalerone | C16H21NO3 | 275.35 | 126 | 127 | 149 | 7.91 | show | SYHGEUNFJIGTRX-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1329-16 | |||
Phenethylamines | Mescaline-NB2OMe | [(2-methoxyphenyl)methyl][2-(3,4,5-trimethoxyphenyl)ethyl]amine | C19H25NO4 | 331.41 | 121 | 150 | 91 | 9.86 | show | USPSMWCGHVXKMN-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1337-16 | ||||
Cathinones | Amfepramone | 2-(diethylamino)-1-phenylpropan-1-one | Diethylpropion, Diethylcathinone, Menutil, Tenuate… | C13H19NO | 205.30 | 100 | 44 | 77 | 3.87 | show | XXEPPPIWZFICOJ-UHFFFAOYSA-N | RM-reference material | 2016-03-11 | RESPONSE project; 2015-2017 | 1323-16 | |||
Opioids | VALERYLFENTANYL | N‐phenyl‐N‐[1‐(2‐phenylethyl)piperidin‐4‐yl]pentanamide | C24H32N2O | 364.52 | 273 | 146 | 189 | show | VCCPXHWAJYWQMR-UHFFFAOYSA-N | analytical report | 2016-03-16 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-16010001 | |||||
Piperazine derivates | Acetildenafil | 5-{2-ethoxy-5-[2-(4-ethylpiperazin-1-yl)acetyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one | C25H34N6O3 | 466.57 | 127 | 70 | 84 | 20.72 | show | RRBRQNALHKQCAI-UHFFFAOYSA-N | test purchase | 2016-03-17 | RESPONSE project; 2015-2017 | 1542-16 | ||||
Piperidines & pyrrolidines | 4-fluoroethylphenidate | ethyl 2-(4-fluorophenyl)-2-(2-piperidyl)acetate | 4F-EPH | C15H20FNO2 | 265.32 | 84 | 109 | 55 | show | RKXQYWFDJDYSEN-UHFFFAOYSA-N | analytical report | 2016-03-22 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-1602005 | ||||
Cannabinoids | 5F-PCN | 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxamide | 5-fluoro MN-21; 5-fluoro PCN | C23H22FN3O | 375.45 | 233 | 145 | 234 | 21.00 | show | BRRZRRZUERBDQL-UHFFFAOYSA-N | RM-reference material | 2016-03-24 | RESPONSE project; 2015-2017 | 1564-16 | |||
Opioids | Despropionyl-2-fluoro fentanyl | N-(2-fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine | despropionyl-o-fluoro fentanyl | C19H23FN2 | 298.40 | 164 | 207 | 44 | show | WUNLGTOLOUTCPE-UHFFFAOYSA-N | analytical report | 2016-03-29 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-15010007 | ||||
Piperidines & pyrrolidines | GTS-21 | (3E)-3-[(2,4-dimethoxyphenyl)methylidene]-3,4,5,6-tetrahydro-2,3'-bipyridine | 3-(2,4-Dimethoxybenzylidene)anabaseine; | C19H20N2O2 | 308.38 | 308 | 293 | 277 | 11.03 | show | RPYWXZCFYPVCNQ-RVDMUPIBSA-N | test purchase | 2016-04-07 | RESPONSE project; 2015-2017 | 1539-16 | |||
Others | PRE-084 | 2-(morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate | Pre-084; CHEMBL305881; 2-morpholin-4-ylethyl 1-phenylcyclohexane-1-carboxylate; Pre 084; Tocris-0589; Lopac-P-2607 | C19H27NO3 | 317.43 | 100 | 113 | 91 | 9.03 | show | RQHKZUBCUZVZEF-UHFFFAOYSA-N | test purchase | 2016-04-18 | RESPONSE project; 2015-2017 | 1544-16 | |||
Others | G-130 | 5,5-dimethyl-2-phenylmorpholine | 2-Phenyl-5,5-dimethyltetrahydro-1,4-oxazine | C12H17NO | 191.27 | 104 | 161 | 105 | 3.85 | show | KJUOROGOOZJYAI-UHFFFAOYSA-N | test purchase | 2016-04-22 | RESPONSE project; 2015-2017 | 1541-16 | |||
Cathinones | PV9 | 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one | α-pyrrolidinooctanophenone, α-POP | C18H27NO | 273.42 | 168 | 169 | 77 | 7.44 | show | RCGHPLZKUHDGCC-UHFFFAOYSA-N | collected | 2016-04-22 | Estonian Forensic Science Institute | 1568-16 | |||
Cannabinoids | AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 2‐({1‐[(4‐fluorophenyl)methyl]‐1H‐indazol‐3‐ yl}formamido)‐3‐methylbutanamide | C20H21FN4O2 | 368.41 | 109 | 253 | 324 | 13.34 | show | AKOOIMKXADOPDA-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1477-16 | |||
Cannabinoids | JWH-250 | 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one | C22H25NO2 | 335.45 | 214 | 144 | 215 | 12.36 | show | FFLSJIQJQKDDCM-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1491-16 | ||||
Cannabinoids | JWH-122 | 3-(4-methylnaphthalene-1-carbonyl)-1-pentyl-1H-indole | (4-Methyl-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone | C25H25NO | 355.48 | 355 | 214 | 298 | 16.09 | show | HUKJQMKQFWYIHS-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1489-16 | |||
Piperazine derivates | BZP | 1-benzylpiperazine | BZP | C11H16N2 | 176.26 | 91 | 134 | 56 | 3.78 | show | IQXXEPZFOOTTBA-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1480-16 | |||
Cannabinoids | JWH-018 | 3-(naphthalene-1-carbonyl)-1-pentyl-1H-indole | AM-678, 1-Pentyl-3-(1-naphthoyl)indole | C24H23NO | 341.45 | 341 | 214 | 284 | 14.88 | show | JDNLPKCAXICMBW-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1485-16 | |||
Cathinones | Methcathinone | 2-(methylamino)-1-phenyl-propan-1-one | Ephedrone | C10H13NO | 163.22 | 58 | 77 | 51 | 2.90 | show | LPLLVINFLBSFRP-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1464-16 | |||
Cannabinoids | 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | AKB48 N-(5-fluoropentyl) analog; 5F-APINACA | C23H30FN3O | 383.51 | 233 | 145 | 294 | 15.71 | show | UCMFSGVIEPXYIV-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1474-16 | |||
Cannabinoids | JWH-073 | naphthalen-1-yl-(1-butylindol-3-yl)methanone | 1-Butyl-3-(1-naphthoyl) indole | C23H21NO | 327.43 | 327 | 200 | 284 | 13.82 | show | VCHHHSMPMLNVGS-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1487-16 | |||
Phenethylamines | 2C-E | 1-(2,5-Dimethoxy-4-ethylphenyl)-2-aminoethane | 2‐(4‐ethyl‐2,5‐dimethoxyphenyl)ethan‐1‐amine | C12H19NO2 | 209.29 | 180 | 165 | 30 | 4.85 | show | VDRGNAMREYBIHA-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1466-16 | |||
Cathinones | Methylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | C11H13NO3 | 207.23 | 58 | 65 | 63 | 5.14 | show | VKEQBMCRQDSRET-UHFFFAOYSA-N | RM-reference material | 2016-05-12 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1498-16 | ||||
Benzodiazepines | Cloniprazepam | 5-(2-chlorophenyl)-1-cyclopropylmethyl-7-nitro-3H-1,4-benzodiazepin-2-one | C19H16ClN3O3 | 369.81 | 340 | 55 | 125 | 13.62 | show | CCSYKGYLSFXNTA-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1575-16 | ||||
Cathinones | PV8 | 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one | α-PEP | C17H25NO | 259.39 | 154 | 155 | 77 | 6.85 | show | DLRWKNLMJAIFQB-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1587-16 | |||
Cathinones | Naphyrone | 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one | Naphthylpyrovalerone | C19H23NO | 281.39 | 126 | 127 | 155 | 8.88 | show | DTNUPBSOODGRKW-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1585-16 | |||
Cathinones | 4-Ethylethcathinone | 2-(ethylamino)-1-(4-ethylphenyl)propan-1-one | 4-ethyl-N-ethylcathinone, 4-EEC, 4-ethylethcathinone | C13H19NO | 205.30 | 72 | 44 | 77 | 4.50 | show | FAXVCSOMTSWQNT-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1582-16 | |||
Benzodiazepines | Pivoxazepam | 7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl pivalate | 7‐chloro‐2‐oxo‐5‐phenyl‐2,3‐dihydro‐1H‐1,4‐ benzodiazepin‐3‐yl 2,2‐dimethylpropanoate | C20H19ClN2O3 | 370.83 | 329 | 313 | 73 | 10.23 | show | FTJLKTBLZOULCL-UHFFFAOYSA-N | RM-reference material | for GC-MS compound was derivatized by MSTFA: GC-RT and MS spectrum refer for TMS derivative. Be aware of possible thermal decomposition in GC. | 2016-05-19 | RESPONSE project; 2015-2017 | 1577-16 | ||
Cathinones | 4-Ethylmethcathinone | 1-(4-ethylphenyl)-2-(methylamino)propan-1-one | 4-Ethylmethcathinone; 4-EMC | C12H17NO | 191.27 | 58 | 77 | 56 | 4.13 | show | FUYPDKFWOHBUFT-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1583-16 | |||
Opioids | FU-F | N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylfuran-2-carboxamide | Furanyl fentanyl | C24H26N2O2 | 374.48 | 283 | 95 | 240 | 13.68 | show | FZJVHWISUGFFQV-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1588-16 | |||
Cannabinoids | LTI-701 | 1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide | C20H21FN2O | 324.40 | 232 | 144 | 233 | 14.05 | show | FZYJALPWLNXEIP-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1580-16 | ||||
Benzodiazepines | Adinazolam | 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | Adinazolamum, Deracyn | C19H18ClN5 | 351.84 | 308 | 310 | 309 | 13.43 | show | GJSLOMWRLALDCT-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1574-16 | |||
Cathinones | 3,4-DMMC | 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | 3,4-Dimethylmethcathinone; 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one; 1-(3,4-dimethylphenyl)-2-methylaminopropan-1-one; 1-Propanone, 1-(3,4-dimethylphenyl)-2-(methylamino)- | C12H17NO | 191.27 | 58 | 77 | 56 | 4.33 | show | IBZRXTVDTGVBIS-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | 2018-04-13 | RESPONSE project; 2015-2017 | 1581-16 | ||
Cannabinoids | JWH-166 | (6-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | JWH 081 6-methoxynaphthyl isomer | C25H25NO2 | 371.48 | 371 | 214 | 354 | 17.14 | show | JCOOBICVPDFZNX-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1578-16 | |||
Cathinones | Mexedrone | 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | MEX, 4-MMC-oMe, | C12H17NO2 | 207.27 | 88 | 56 | 91 | 4.54 | show | JHGDCSPZKQLBOP-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1584-16 | |||
Plants & extracts | Mitragynine | (E)-2-[(2S,3S)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b- octahydroindolo[3,2-h]quinolizin-2-yl]-3- methoxyprop-2-enoic acid methyl ester | methyl (2E)‐2‐[(2S,3S)‐3‐ethyl‐8‐methoxy‐ 1H,2H,3H,4H,6H,7H,12H,12bH‐indolo[2,3‐a]quinolizin‐2‐ yl]‐3‐methoxyprop‐2‐enoate | C23H30N2O4 | 398.50 | 214 | 397 | 398 | 16.35 | show | LELBFTMXCIIKKX-JLIIPWMNSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1590-16 | |||
Benzodiazepines | Metizolam | 7-(2-chlorophenyl)-4-ethyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | Desmethyletizolam; 4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | C16H13ClN4S | 328.82 | 328 | 299 | 330 | 12.86 | show | NQSSWDKQLVBUQN-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1576-16 | |||
Cannabinoids | JWH-368 | [5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | C26H24FNO | 385.48 | 385 | 155 | 127 | 15.65 | show | OCOICOMCAJNSCA-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1579-16 | ||||
Cathinones | NiPP | 2-(Isopropylamino)-1-phenylpentan-1-one | 2-IPP, NPP, 1-phenyl-2-(1-methylethylamino)pentan-1-one, N-isopropylpentedrone, NiPP | C14H21NO | 219.33 | 114 | 72 | 77 | 4.21 | show | YKMMLFOYDTYAGR-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1586-16 | |||
Phenethylamines | 25I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | 2C-I-NBOMe, Cimbi5 | C18H22INO3 | 427.28 | 121 | 150 | 91 | 11.23 | show | ZFUOLNAKPBFDIJ-UHFFFAOYSA-N | RM-reference material | 2016-05-19 | RESPONSE project; 2015-2017 | 1589-16 | |||
Cannabinoids | JWH-200 | 1-[2-(morpholin-4-yl)ethyl]-3-(naphthalene-1-carbonyl)-1H-indole | (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone | C25H24N2O2 | 384.48 | 100 | 127 | 56 | 18.38 | show | SZWYXJHTNGJPKU-UHFFFAOYSA-N | RM-reference material | 2016-05-23 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1496-16 | |||
Benzodiazepines | Ro5-4864_(Chlorodiazepam) | 7-Chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | 4'-Chlorodiazepam; Ro 5-4864; 4-Chlorodiazepam; RO5-4864; Chlorodiazepam | C16H12Cl2N2O | 319.19 | 290 | 317 | 292 | 10.59 | show | PUMYFTJOWAJIKF-UHFFFAOYSA-N | test purchase | 2016-05-24 | 2016-08-11 | RESPONSE project; 2015-2017 | 1567-16 | ||
Others | 3-Methylphenmetrazine | 3‐methyl‐2‐(3‐methylphenyl)morpholine | 3-Methylphenmetrazine, 3-MPM, 3-MPH, 3-methyl-2-(m-tolyl)morpholin | C12H17NO | 191.27 | 71 | 56 | 42 | 4.09 | show | QEDQZYNGDXULGO-UHFFFAOYSA-N | test purchase | 2016-05-24 | RESPONSE project; 2015-2017 | 1540-16 | |||
Piperidines & pyrrolidines | 4F-EPH | ethyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | p-fluoroethylphenidate, 4F-EPH, 4-fluoroethylphenidate | C15H20FNO2 | 265.33 | 84 | 109 | 56 | 5.71 | show | RKXQYWFDJDYSEN-UHFFFAOYSA-N | test purchase | 2016-05-24 | RESPONSE project; 2015-2017 | 1563-16 | |||
Cathinones | Pentylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one | β-keto-methylbenzodioxolylpentanamine; βk-{N-methyl-1-(1,3-benzodioxol-5-yl)-2-pentanamine; βk-MBDP | C13H17NO3 | 235.28 | 86 | 149 | 65 | 6.21 | show | DFMLULIEUUXXSA-UHFFFAOYSA-N | test purchase | purchased as 2-NMC | 2016-05-31 | RESPONSE project; 2015-2017 | 1533-16 | ||
Others | Methylmorphenate | methyl 2-(morpholin-3-yl)-2-phenylacetate | C13H17NO3 | 235.28 | 86 | 91 | 150 | 5.61 | show | FTSNQYGFVFQKHY-UHFFFAOYSA-N | test purchase | 2016-05-31 | RESPONSE project; 2015-2017 | 1538-16 | ||||
Benzodiazepines | Metizolam | 7-(2-chlorophenyl)-4-ethyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | Desmethyletizolam; 4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | C16H13ClN4S | 328.82 | 328 | 299 | 330 | 12.87 | show | NQSSWDKQLVBUQN-UHFFFAOYSA-N | test purchase | 2016-05-31 | RESPONSE project; 2015-2017 | 1562-16 | |||
Opioids | Carfentanil | methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | 4-[(1-Oxopropyl)phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylic Acid Methyl Ester | C24H30N2O3 | 394.52 | 303 | 304 | 105 | 12.06 | show | YDSDEBIZUNNPOB-UHFFFAOYSA-N | RM-reference material | 2016-07-05 | RESPONSE project; 2015-2017 | 1375-16 | |||
Aminoindanes | 5-IAI | 5-Iodo-2,3-dihydro-1H-inden-2-amine | 2,3-dihydro-5-iodo-1H-inden-2-amine; 5-Iodo-2-aminoindane | C9H10IN | 259.09 | 259 | 115 | 117 | 4.82 | show | BIHPYCDDPGNWQO-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1599-16 | |||
Cannabinoids | 5-fluoro-SDB-005 | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | 5F-SDB-005 | C23H21FN2O2 | 376.43 | 233 | 145 | 115 | 15.70 | show | FNMFGMMHNFDPNT-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1605-16 | |||
Aminoindanes | MDAI | 2H,5H,6H,7H-indeno[5,6-d][1,3]dioxol-6-amine | 5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f] [1,3]benzodioxol-6-amine | C10H11NO2 | 177.20 | 160 | 149 | 177 | 4.33 | show | FQDRMHHCWZAXJM-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1597-16 | |||
Arylcyclohexylamines | deschloro-N-ethyl-ketamine | 2-(ethylamino)-2-phenylcyclohexan-1-one | 2-(ethylamino)-2-phenyl-cyclohexanone; Eticyclidone; O-PCE; 2-Oxo-PCE | C14H19NO | 217.31 | 160 | 104 | 189 | 5.14 | show | IDLSBAANXISGEI-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1607-16 | |||
Aminoindanes | 2-AI | 2,3-dihydro-1H-inden-2-amine | 2-Aminoindane | C9H11N | 133.19 | 133 | 116 | 91 | 2.50 | show | LMHHFZAXSANGGM-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1598-16 | |||
Cannabinoids | PX 2 | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide; 5-fluoro APP-PINACA; FU-PX; 5F-APP-PINACA | C22H25FN4O2 | 396.50 | 233 | 145 | 352 | 16.60 | show | OJTAHWMZBJRSIR-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1609-16 | |||
Others | 2-Isovaleryl-1_3-indanedione | 2-isovalerylindan-1,3-dione | 2-(3-methylbutanoyl)-1H-indene-1,3(2H)-dione; 2-(3-methyl-1-oxobutyl)-1H-indene-1,3(2H)-dione; Valone; Isoval; 2-Isovaleryl-1,3-indanedione; Isovaleryl indandione; 2-Isovaleryl-1,3-indandione | C14H14O3 | 230.26 | 173 | 174 | 146 | 6.06 | show | PVWMAOPFDINGAY-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1600-16 | |||
Cannabinoids | SDB-006 N-phenyl analog | 1-pentyl-N-phenyl-1H-indole-3-carboxamide | C20H22N2O | 306.41 | 214 | 144 | 215 | 13.00 | show | SPUQBSMPSCYQLS-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1606-16 | ||||
Aminoindanes | N-methyl-2AI | N-methyl-2,3-dihydro-1H-inden-2-amine | 2,3-dihydro-N-methyl-1H-inden-2-amine NM-2AI N-methyl-2-Aminoindane | C10H13N | 147.22 | 147 | 42 | 106 | 2.75 | show | SXWZQUCTTOBHJT-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1596-16 | |||
Phenethylamines | 25G_NBOMe | [2-(2,5-dimethoxy-3,4-dimethylphenyl)ethyl][(2-methoxyphenyl)methyl]amine | NBOMe-2CG; 2C-G-NBOMe; 2,5-Dimethoxy-N-(2-methoxybenzyl)-3,4-dimethylphenethylamine | C20H27NO3 | 329.44 | 121 | 150 | 91 | 9.93 | show | VDAUMFACIMNTDA-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1604-16 | |||
Cannabinoids | 5-fluoro-JWH-018-adamantyl analog | 3-(adamantane-1-carbonyl)-1-(5-fluoropentyl)-1H-indole | [1-(5-fluoropentyl)-1H-indol-3-yl]tricyclo[3.3.1.13,7]dec-1-yl-methanone; 5F-AB-001; AM2201 adamantyl analog | C24H30FNO | 367.51 | 232 | 144 | 233 | 15.37 | show | WBLLMFXPGHZFFP-UHFFFAOYSA-N | RM-reference material | 2016-07-18 | RESPONSE project; 2015-2017 | 1608-16 | |||
Cathinones | 4F-α-PVP | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone | 4-fluoro-α-PVP; 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-pentan-1-one 4-fluoro-α-Pyrrolidinopentiophenone; 4-fluoro-α-2-(1-pyrrolidinyl)-Valerophenone; 4F-alpha-PVP; 4-fluoro-α-PVP | C15H20FNO | 249.33 | 126 | 95 | 127 | 5.45 | show | BQLSUBYYRRZHRK-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1610-16 | |||
Cathinones | 4-Fluorobuphedrone | 1-(4-fluorophenyl)-2-(methylamino)butan-1-one | 4-FBP, 4-F-MABP; 4F-buphedrone | C11H14FNO | 195.24 | 72 | 95 | 57 | 3.13 | show | NEZHKHMZNSFKGS-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1615-16 | |||
Phenethylamines | 25I-NBMD | [(2H-1,3-benzodioxol-4-yl)methyl][2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amine | Cimbi-29 | C18H20INO4 | 441.26 | 135 | 164 | 77 | 12.22 | show | NJNMIPDEUMTYNV-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1614-16 | |||
Arylcyclohexylamines | 2-methoxy Ketamine | 2-(2-methoxyphenyl)-2-(methylamino)cyclohexan-1-one | C14H19NO2 | 233.31 | 176 | 148 | 205 | 6.02 | show | OYAUVHORXFUVAJ-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1613-16 | ||||
Arylcyclohexylamines | PCEEA | N-(2-ethoxyethyl)-1-phenylcyclohexanamine | C16H25NO | 247.38 | 91 | 159 | 204 | 6.02 | show | PRQVCBDFWYTXDD-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1612-16 | ||||
Phenethylamines | 25E-NBOMe | 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine | 2C-E-NBOMe; NBOMe-2C-E | C20H27NO3 | 329.44 | 121 | 91 | 150 | 9.69 | show | PXDVGFGXPVCNAB-UHFFFAOYSA-N | RM-reference material | 2016-07-19 | RESPONSE project; 2015-2017 | 1611-16 | |||
Cathinones | 4F-alpha-PVP | 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one; | 4-fluoro-alpha-2-(1-pyrrolidinyl)-valerophenone; 4-fluoro-alpha-pyrollidinovalerophenone; 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)-1-pentanone | C15H20FNO | 249.32 | 126 | 95 | show | BQLSUBYYRRZHRK-UHFFFAOYSA-N | analytical report | 2016-07-22 | Hungarian Institute of Forensic Science, Budapest, Hungary | RPT: HIFS-002 | |||||
Phenethylamines | Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | MNA, MNT, N-methyl-PAL-287, methylnaphetamine, Methamnetamine | C14H17N | 199.29 | 58 | 115 | 141 | show | BWWWOLYZMKACSB-UHFFFAOYSA-N | analytical report | 2016-07-22 | Hungarian Institute of Forensic Science, Budapest, Hungary | RPT: HIFS-004 | ||||
Cannabinoids | Cumyl-4CN-BINACA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | SGT-78, CUMYL-CYBINACA, Cumyl-CB-PINACA | C22H24N4O | 360.45 | 226 | 345 | 145 | show | JGTSOWOPISVAHG-UHFFFAOYSA-N | analytical report | 2016-07-22 | Hungarian Institute of Forensic Science, Budapest, Hungary | RPT: HIFS-001 | ||||
Cathinones | Dipentylone | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 2 (dimethylamino) 3’,4’ (methylendioxy)valerophenone | C14H19NO3 | 249.31 | 100 | 58 | 71 | show | PQTJKFUXRBKONZ-UHFFFAOYSA-N | analytical report | 2016-07-22 | Hungarian Institute of Forensic Science, Budapest, Hungary | RPT: HIFS-005 | ||||
Arylcyclohexylamines | Deschloroketamine | 2-(methylamino)-2-phenylcyclohexan-1-one | 2-(methylamino)-2-phenylcyclohexanone | C13H17NO | 203.28 | 146 | 175 | 104 | show | ZAGBSZSITDFFAF-UHFFFAOYSA-N | analytical report | 2016-07-22 | Hungarian Institute of Forensic Science, Budapest, Hungary | RPT: HIFS-003 | ||||
Opioids | Acryloyl-F | N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide | Acrylfentanyl; Acryloylfentanyl; ACF; 1-phenethyl-4-N-acryloylanilinopiperidine; Acryloyl-F | C22H26N2O | 334.46 | 243 | 146 | 200 | 11.17 | show | RFQNLMWUIJJEQF-UHFFFAOYSA-N | test purchase | 2016-07-27 | RESPONSE project; 2015-2017 | 1565-16 | |||
Phenethylamines | 25H-NBOMe | [2-(2,5-dimethoxyphenyl)ethyl][(2-methoxyphenyl)methyl]amine | 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 2C-H-NBOMe | C18H23NO3 | 301.39 | 121 | 150 | 91 | 9.21 | show | RMLXCDMTGWSEOU-UHFFFAOYSA-N | RM-reference material | 2016-07-27 | RESPONSE project; 2015-2017 | 1625-16 | |||
Phenethylamines | 30C-NBOMe | [2-(4-chloro-2,5-dimethoxyphenyl)ethyl][(3,4,5-trimethoxyphenyl)methyl]amine | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine | C20H26ClNO5 | 395.88 | 181 | 182 | 210 | 12.31 | show | ZQYYVTABADQBTJ-UHFFFAOYSA-N | RM-reference material | 2016-07-27 | RESPONSE project; 2015-2017 | 1624-16 | |||
Phenethylamines | 25T-NBOMe | {2-[2,5-dimethoxy-4-(methylsulfanyl)phenyl]ethyl}[(2-methoxyphenyl)methyl]amine | 2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-4-(methylthio)-benzeneethanamine; 2C-T-NBOMe; 25T2-NBOMe; | C19H25NO3S | 347.47 | 121 | 91 | 150 | 11.09 | show | ZWPIZVVOKGWMFW-UHFFFAOYSA-N | RM-reference material | 2016-07-27 | RESPONSE project; 2015-2017 | 1623-16 | |||
Opioids | 4Cl-iBF | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide | 4-Cl-iBF | C23H29ClN2O | 384.95 | 293 | 223 | 180 | 12.22 | show | YWHLYGSHOQKCJG-UHFFFAOYSA-N | test purchase | 2016-07-29 | RESPONSE project; 2015-2017 | 1566-16 | |||
Others | Indane | 2,3-dihydro-1H-indene | 1,2-hydrindene, hydrindonaphthene, hydrindene | C9H10 | 118.18 | 117 | 118 | 115 | 2.09 | show | PQNFLJBBNBOBRQ-UHFFFAOYSA-N | RM-reference material | 2016-08-03 | RESPONSE project; 2015-2017 | 1618-16 | |||
Others | 1,3-Indanedione | 2,3-dihydro-1H-indene-1,3-dione | 1,3-Dioxoindan | C9H6O2 | 146.15 | 146 | 104 | 76 | 2.90 | show | UHKAJLSKXBADFT-UHFFFAOYSA-N | RM-reference material | 2016-08-03 | RESPONSE project; 2015-2017 | 1617-16 | |||
Arylcyclohexylamines | Ketamine related compound A | 1-[(2-chlorophenyl)(methylimino)methyl]cyclopentan-1-ol | 1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentanol | C13H16ClNO | 237.73 | 152 | 154 | 138 | 5.51 | show | FJGPXUPMNZOTLX-UHFFFAOYSA-N | RM-reference material | 2016-08-10 | RESPONSE project; 2015-2017 | 1601-16 | |||
Benzodiazepines | Nitrazolam | 3-methyl-12-nitro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.02,6]tetradeca-1(14),3,5,8,10,12-hexaene | 1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | C17H13N5O2 | 319.32 | 302 | 204 | 272 | 14.61 | show | OYRPNABWTHDOFK-UHFFFAOYSA-N | collected | 2016-08-10 | Institute of forensic medicine, University of Freiburg, Germany (NMR confirmed sample). | 1452-16 | |||
Opioids | 4F-iBF | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | N-(4-Fluorophenyl)-N-(1-phenethyl-4-piperidinyl)isobutyramide; 4-fluoro-isobutrylfentanyl | C23H29FN2O | 368.50 | 277 | 207 | 164 | 10.78 | show | OZDOSQNUJIXEOR-UHFFFAOYSA-N | test purchase | 2016-08-10 | RESPONSE project; 2015-2017 | 1573-16 | |||
Phenethylamines | Methamnetamine | N-methyl-1-(naphthalen-2-yl)propan-2-amine | MNA, MNT, N-methyl-PAL-287, methylnaphetamine, Methamnetamine | C14H17N | 199.30 | 58 | 115 | 141 | 5.35 | show | BWWWOLYZMKACSB-UHFFFAOYSA-N | collected | 2016-08-12 | 2017-08-02 | Institute of forensic medicine, University of Freiburg, Germany. | 1440-16 | ||
Piperazine derivates | Sunifiram | 1-(4-benzoylpiperazin-1-yl)propan-1-one | DM-235 | C14H18N2O2 | 246.30 | 105 | 85 | 77 | 8.61 | show | DGOWDUFJCINDGI-UHFFFAOYSA-N | test purchase | Nootropic | 2016-08-12 | RESPONSE project; 2015-2017 | 1537-16 | ||
Piperazine derivates | Methoxypiperamide | 1-(4-methoxybenzoyl)-4-methylpiperazine | (4-Methoxyphenyl)(4-methylpiperazin-1-yl)methanone; Methoxypiperamide; MEXP, MeOP | C13H18N2O2 | 234.30 | 70 | 135 | 83 | 7.40 | show | DWPVVZZGGGCRRM-UHFFFAOYSA-N | collected | 2016-08-16 | Institute of forensic medicine, University of Freiburg, Germany. | 1439-16 | |||
Others | Nitracaine | 3-(diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate | N,N-diethyl-2,2-dimethyl-3-((4-nitrobenzoyl)oxy)propan-1-amin | C16H24N2O4 | 308.38 | 86 | 87 | 58 | 8.05 | show | SPTIETJWCCCJSE-UHFFFAOYSA-N | collected | 2016-08-25 | Institute of forensic medicine, University of Freiburg, Germany. | 1443-16 | |||
Benzodiazepines | Fonazepam | 5-(2-fluoro-phenyl)-7-nitro-1,3-dihydro benzo[e][1,4]diazepin-2-one | N-desmethylflunitrazepam; desmethylflunitrazepam; norflunitrazepam; demethylflunitrazepam; Ro 5-4435 | C15H10FN3O3 | 299.26 | 298 | 224 | 271 | 10.68 | show | KNGIGRDYBQPXKQ-UHFFFAOYSA-N | collected | 2016-08-31 | Institute of forensic medicine, University of Freiburg, Germany. | 1646-16 | |||
Cannabinoids | JWH-308 | 2-(4-fluorophenyl)-4-(naphthalene-1-carbonyl)-1-pentyl-1H-pyrrole | 1-pentyl-3-(1-naphthoyl)-5-(4-fluorophenyl)-pyrrole; (5-(4-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | C26H24FNO | 385.48 | 155 | 127 | 385 | 15.66 | show | PJNACIYIFHTDCK-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1654-16 | |||
Cannabinoids | 5F-MDMB-PINACA | methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoate | 5F-ADB, ADB-5F, 5F-methyl-AMB, 5-fluoro-MAMB | C20H28FN3O3 | 377.46 | 233 | 145 | 131 | 10.58 | show | PWEKNGSNNAKWBL-QGZVFWFLSA-N | RM-reference material | (impurity detected by GC-MS) | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1652-16 | ||
Arylcyclohexylamines | Tiletamine | 2-(ethylamino)-2-(thiophen-2-yl)cyclohexan-1-one | C12H17NOS | 223.33 | 166 | 110 | 195 | 5.10 | show | QAXBVGVYDCAVLV-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | 2018-04-11 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1645-16 | |||
Cannabinoids | JWH-369 | 2-(2-chlorophenyl)-4-(naphthalene-1-carbonyl)-1-pentyl-1H-pyrrole | [5-(2-chlorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | C26H24ClNO | 401.93 | 155 | 127 | 401 | 16.75 | show | SUELCWQJMQQCTF-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1653-16 | |||
Phenethylamines | 25B-NBOMe | [2-(4-bromo-2,5-dimethoxyphenyl)ethyl][(2-methoxyphenyl)methyl]amine | NBOMe-2C-B, Cimbi-36, Nova, BOM 2-CB, 2C-B-NBOMe | C18H22BrNO3 | 380.28 | 121 | 150 | 91 | 10.54 | show | SUXGNJVVBGJEFB-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1649-16 | |||
Phenethylamines | TMA-2 | 1-(2,4,5-trimethoxyphenyl)propan-2-amine | CHEMBL8389 | C12H19NO3 | 225.29 | 44 | 182 | 167 | 5.23 | show | TVSIMAWGATVNGK-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1651-16 | |||
Phenethylamines | 2C-B-fly | 2-{8-bromo-4,10-dioxatricyclo[7.3.0.03,7]dodeca-1,3(7),8-trien-2-yl}ethan-1-amine | 2C-bromo-fly | C12H14BrNO2 | 284.15 | 254 | 256 | 115 | 8.19 | show | YZDFADGMVOSVIX-UHFFFAOYSA-N | RM-reference material | 2016-09-08 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1647-16 | |||
Phenethylamines | 5-MAPDI | [1‐(2,3‐dihydro‐1H‐inden‐5‐yl)propan‐2‐yl](methyl)amine | indanylmethylaminopropane, 1-(2,3-dihydro-1H-inden-5-yl)-N-methylpropan-2-amine, IMA , IMP , Indanylmethylaminopropane , N-Methyl-3,4-trimethyleneamphetamine | C13H19N | 189.30 | 58 | 115 | 56 | 4.19 | show | MHBKJTHGGWQKSG-UHFFFAOYSA-N | test purchase | 2016-09-13 | RESPONSE project; 2015-2017 | 1658-16 | |||
Benzodiazepines | Meclonazepam | 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | 3-methylclonazepam | C16H12ClN3O3 | 329.74 | 294 | 288 | 286 | 11.60 | show | LMUVYJCAFWGNSY-UHFFFAOYSA-N | test purchase | 2016-09-15 | RESPONSE project; 2015-2017 | 1670-16 | |||
Indolalkylamines (fe tryptamines) | 4-AcO-DMT | 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate | 4-acetoxy-N,N-dimethyltryptamine, O-Acetylpsilocin, Psilacetin, 4-Acetoxy-DMT | C14H18N2O2 | 246.31 | 58 | 146 | 59 | 7.81 | show | RTLRUOSYLFOFHV-UHFFFAOYSA-N | test purchase | 2016-09-15 | RESPONSE project; 2015-2017 | 1667-16 | |||
Piperidines & pyrrolidines | 4-Me-TMP | methyl-2-(4-methylphenyl)-2-(piperidin-2-yl)acetate | methyl 2-(2-piperidyl)-2-(p-tolyl)acetate, threo-4-Methylmethylphenidate, 4-Methylmethylphenidate, 4MeTMP | C15H21NO2 | 247.34 | 84 | 105 | 164 | 6.07 | show | WJZNCJIOIACDBR-UHFFFAOYSA-N | test purchase | 2016-09-15 | RESPONSE project; 2015-2017 | 1669-16 | |||
Cannabinoids | AMB-FUBICA | methyl 2‐({1‐[(4‐fluorophenyl)methyl]‐1H‐indol‐3‐yl}formamido)‐3‐methylbutanoate | FUB-AMB-indole; MMB-FUBICA; (N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine, methyl ester (Cayman- L- isomer defined) | C22H23FN2O3 | 382.43 | 109 | 252 | 268 | 13.21 | show | NYQOGZPXNJSYDW-UHFFFAOYSA-N | test purchase | 2016-09-21 | RESPONSE project; 2015-2017 | 1657-16 | |||
Indolalkylamines (fe tryptamines) | 4-HO-MiPT | 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol | 4-hydroxy-N,N-methylisopropyltryptamine; miprocin, 4-hydroxy-N-methyl-N-isopropyltryptamine | C14H20N2O | 232.33 | 86 | 232 | 146 | 7.97 | show | RXKGHZCQFXXWFQ-UHFFFAOYSA-N | test purchase | 2016-09-21 | RESPONSE project; 2015-2017 | 1664-16 | |||
Indolalkylamines (fe tryptamines) | ETH-LAD | N,N,6-triethyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide | N-ethyl-nor-LSD | C21H27N3O | 337.47 | 235 | 181 | 337 | 15.27 | show | MYNOUXJLOHVSMQ-UHFFFAOYSA-N | collected | 2016-09-22 | RESPONSE project; 2015-2017 | 1678-16 | |||
Arylalkylamines | 6-IT | 1-(1H-indol-6-yl)propan-2-amine | (2-(1H-Indol-6-yl)-1-methylethyl)amine; [2-(1H-Indol-6-yl)-1-methylethyl]amine; 6-Aminopropylindole; alpha-methyl-1H-indole-6-ethanamine | C11H14N2 | 174.25 | 131 | 44 | 130 | 5.48 | show | QCFIFKAOUKPFPU-UHFFFAOYSA-N | RM-reference material | 2016-09-22 | RESPONSE project; 2015-2017 | 1644-16 | |||
Cathinones | 4-MPD | 2-(methylamino)-1-(4-methylphenyl)pentan-1-one | 4-Methylpentedrone; 1-(4-Methylphenyl)-2-methylamino-pentan-1-one; 2-(methylamino)-1-(p-tolyl)pentan-1-one | C13H19NO | 205.30 | 86 | 44 | 91 | 4.48 | show | AKVKBEDACKJNPO-UHFFFAOYSA-N | collected | 2016-09-30 | FSI Ivan Vučetić, Zagreb, Croatia (NMR confirmed sample) | 1695-16 | |||
Others | Phenibut | 4-amino-3-phenylbutanoic acid | Fenibut, Phenygam, Phenylgamma, PHG, PhGABA | C10H13NO2 | 179.22 | 104 | 161 | 103 | 5.07 | show | DAFOCGYVTAOKAJ-UHFFFAOYSA-N | seized | 2016-09-30 | Slovenian Customs Laboratory | 1674-16 | |||
Cannabinoids | 5F-PB-22 | quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | 5-fluoro QUPIC, 5-fluoro-PB-22 | C23H21FN2O2 | 376.43 | 232 | 144 | 233 | 17.11 | show | MBOCMBFDYVSGLJ-UHFFFAOYSA-N | seized | 2016-10-03 | RESPONSE project; 2015-2017 | 1673-16 | |||
Piperidines & pyrrolidines | Coluracetam | N-{2,3-dimethyl-5H,6H,7H,8H-furo[2,3-b]quinolin-4-yl}-2-(2-oxopyrrolidin-1-yl)acetamide | BCI-540, MKC-231 | C19H23N3O3 | 341.40 | 98 | 215 | 70 | 15.63 | show | PSPGQHXMUKWNDI-UHFFFAOYSA-N | test purchase | nootropic | 2016-10-03 | RESPONSE project; 2015-2017 | 1677-16 | ||
Phenethylamines | 25C-NB3OMe | [2-(4-chloro-2,5-dimethoxyphenyl)ethyl][(3-methoxyphenyl)methyl]amine | N-(3-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethylamine; 3-Methoxy-25C-NBOMe | C18H22ClNO3 | 335.83 | 121 | 150 | 91 | 10.34 | show | CSLNJUOCJZCEIR-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1688-16 | |||
Cathinones | TH-PBP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)butan-1-one | 3',4'-tetramethylene-alpha-Pyrrolidinobutiophenone | C18H25NO | 271.40 | 112 | 113 | 91 | 8.45 | show | DNKYSKGKPOHTKY-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1684-16 | |||
Arylalkylamines | 5-AEDB | 2-(2,3-dihydro-1-benzofuran-5-yl)ethan-1-amine | 5-(2-Aminoethyl)-2,3-dihydrobenzofuran | C10H13NO | 163.22 | 134 | 133 | 30 | 3.97 | show | GDRWGOBKFDGTJB-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1679-16 | |||
Arylalkylamines | TDIQ | 2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinoline | 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline; MDTHIQ; 6,7-Methylenedioxy-1,2,3,4-tetrahydroisoquinoline | C10H11NO2 | 177.20 | 148 | 176 | 177 | 4.75 | show | JHLDJOBIUVJSTG-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1682-16 | |||
Cathinones | 3,4-Trimethylene-alpha-PVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | 3',4'-trimethylene-.alpha.-Pyrrolidinovalerophenone; Indanyl-.alpha.-PVP; 3',4'-trimethylene-.alpha.-PVP; | C18H25NO | 271.40 | 126 | 127 | 115 | 8.13 | show | NBZPCEWLKPSIIL-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1683-16 | |||
Phenethylamines | DOBU | 1-(4-butyl-2,5-dimethoxyphenyl)propan-2-amine | 4-butyl-2,5-dimethoxy-alpha-methyl-benzeneethanamine | C15H25NO2 | 251.37 | 208 | 165 | 209 | 6.04 | show | NGVDYAULSQKEGW-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1689-16 | |||
Phenethylamines | DOAM | 1-(2,5-dimethoxy-4-pentylphenyl)propan-2-amine | 2,5-Dimethoxy-4-amylamphetamine; 2,5-Dimethoxy-4-pentylamphetamine | C16H27NO2 | 265.40 | 222 | 165 | 223 | 6.63 | show | VLJORLCVOAUUKM-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1690-16 | |||
Indolalkylamines (fe tryptamines) | 6-MeO-DiPT | [2-(6-methoxy-1H-indol-3-yl)ethyl]bis(propan-2-yl)amine | 6-methoxy-N,N-Diisopropyltryptamine; 6-Methoxy DiPT; 6-methoxy-N,N-bis(1-methylethyl)-1H-indole-3-ethanamine | C17H26N2O | 274.41 | 114 | 72 | 160 | 8.81 | show | VVHSFCPALYIWMT-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1693-16 | |||
Phenethylamines | 2C-iP | 2-[2,5-dimethoxy-4-(propan-2-yl)phenyl]ethan-1-amine | 2-(4-isopropyl-2,5-dimethoxyphenyl)ethan-1-amine | C13H21NO2 | 223.32 | 194 | 179 | 30 | 5.09 | show | XUGPCRRUMVWELT-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1691-16 | |||
Cannabinoids | EMB-FUBINACA | ethyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate | 5-fluoro EMB-FUBINACA; FU-AEB; ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate | C22H24FN3O3 | 397.44 | 253 | 109 | 324 | 12.02 | show | YOECWCNJGHHTMN-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | 2016-11-14 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1686-16 | ||
Cathinones | 3,4-Trimethylenepentedrone | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)pentan-1-one | 3',4'-trimethylene-.alpha.-methylamino-Valerophenone; Indanylpentedrone | C15H21NO | 231.34 | 86 | 115 | 87 | 6.49 | show | ZCTUUSNQUQURDL-UHFFFAOYSA-N | RM-reference material | 2016-10-10 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1680-16 | |||
Phenethylamines | 2C-P-NBOMe | [2-(2,5-dimethoxy-4-propylphenyl)ethyl][(2-methoxyphenyl)methyl]amine | 25P-NB2OMe; 2-(4-Propyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | C21H29NO3 | 343.46 | 121 | 150 | 91 | 10.09 | show | QHEBYIJRKGDFGH-UHFFFAOYSA-N | RM-reference material | 2016-10-13 | 2018-05-28 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1681-16 | ||
Arylcyclohexylamines | 3-MeO-PCMMo | 4-((1-(3-methoxyphenyl)cyclohexyl)methyl)morpholine | C18H27NO2 | 289.40 | 100 | 101 | 56 | 8.09 | show | KVDDTOKOCUZIFC-UHFFFAOYSA-N | test purchase | 2016-10-18 | RESPONSE project; 2015-2017 | 1662-16 | ||||
Cannabinoids | 5F-MDMB-PICA | methyl 2-{[1-(5-fluoropentyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate | 5F-MDMB-2201, MDMB-2201 | C21H29FN2O3 | 376.46 | 232 | 144 | 233 | show | CHSUEEBESACQDV-UHFFFAOYSA-N | analytical report | 2016-10-20 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-16100003 | ||||
Cannabinoids | CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | SGT-78, CUMYL-CYBINACA; Cumyl-CB-PINACA | C22H24N4O | 360.45 | 226 | 345 | 145 | 14.04 | show | JGTSOWOPISVAHG-UHFFFAOYSA-N | test purchase | purchased as R-30490 | 2016-10-24 | RESPONSE project; 2015-2017 | 1666-16 | ||
Cannabinoids | MN-24 | N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide | JWH-018 Carboxamide Derivative, MN-24, NNEI, AM-6527 | C24H24N2O | 356.47 | 214 | 144 | 215 | 18.12 | show | GWCQNKRMTGVYIZ-UHFFFAOYSA-N | collected | 2016-10-25 | Institute of forensic medicine, University of Freiburg, Germany. | 1457-16 | |||
Cathinones | 4-MEAP | 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one | 4-Methyl-N-ethylnorpentedrone; 2-(ethylamino)-4'-methyl- valerophenone; 1-p-Tolyl-2-ethylamino-pentanone-(1) | C14H21NO | 219.33 | 100 | 58 | 91 | 4.85 | show | IKIANZXWCBSIGA-UHFFFAOYSA-N | collected | 2016-10-25 | FSI Ivan Vučetić, Zagreb, Croatia (NMR confirmed sample) | 1696-16 | |||
Cannabinoids | EG-2201 | 9-(5-fluoropentyl)-3-(naphthalene-1-carbonyl)-9H-carbazole | (9-(5-fluoropentyl)-9H-carbazol-3-yl)(naphthalen-1-yl)methanone | C28H24FNO | 409.50 | 334 | 409 | 127 | 21.95 | show | LYDDINAZVHIBGP-UHFFFAOYSA-N | collected | 2016-10-25 | 2018-04-13 | Institute of forensic medicine, University of Freiburg, Germany. | 1461-16 | ||
Cannabinoids | A-834735 | 1-[(oxan-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | [1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone | C22H29NO2 | 339.48 | 242 | 324 | 69 | 11.48 | show | NQTMRZNYLIGQCF-UHFFFAOYSA-N | collected | 2016-10-25 | Institute of forensic medicine, University of Freiburg, Germany. | 1453-16 | |||
Phenethylamines | 25N-NBOMe | 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine | 2C-N-NBOMe, NBOMe-2C-N | C18H22N2O5 | 346.38 | 121 | 91 | 150 | 11.42 | show | TXCKTIBHURMASQ-UHFFFAOYSA-N | RM-reference material | 2016-10-26 | RESPONSE project; 2015-2017 | 1621-16 | |||
Phenethylamines | 25I-NBOMe-metabolite | 4-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl)-3-methoxyphenol | 2C-I-NBOMe-M1 | C18H22INO4 | 443.28 | 137 | 290 | 179 | 17.02 | show | SOVZUKWDXFGFTI-UHFFFAOYSA-N | RM-reference material | GC-RT and MS spectrum refer for acetyl derivative of compound, non dervatized compound decomposed to 2C-I | 2016-10-27 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1656-16 | ||
Opioids | Valerylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide | Penta-Fentanyl, fentanyl pentanamide analogue, TCE, VF | C24H32N2O | 364.52 | 273 | 146 | 189 | 12.28 | show | VCCPXHWAJYWQMR-UHFFFAOYSA-N | test purchase | 2016-10-27 | RESPONSE project; 2015-2017 | 1665-16 | |||
Indolalkylamines (fe tryptamines) | 7-MeO-DiPT | [2-(7-methoxy-1H-indol-3-yl)ethyl]bis(propan-2-yl)amine | 7-methoxy-N,N-Diisopropyltryptamine; 7-MeO DiPT; N-isopropyl-N-(2-(7-methoxy-1H-indol-3-yl)ethyl)propan-2-amine | C17H26N2O | 274.41 | 114 | 72 | 115 | 8.37 | show | CYDOUMFFIKOFBJ-UHFFFAOYSA-N | RM-reference material | 2016-11-17 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1694-16 | |||
Indolalkylamines (fe tryptamines) | 5-MeO-EPT | ethyl[2-(5-methoxy-1H-indol-3-yl)ethyl]propylamine | 5-Methoxy-EPT; 5-methoxy-N-ethyl-N-Propyltryptamine; N-ethyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)propan-1-amine | C16H24N2O | 260.38 | 100 | 58 | 101 | 8.33 | show | OQHFIOKNGNJPPF-UHFFFAOYSA-N | RM-reference material | 2016-11-17 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1687-16 | |||
Indolalkylamines (fe tryptamines) | 4-MeO-DiPT | [2-(4-methoxy-1H-indol-3-yl)ethyl]bis(propan-2-yl)amine | 4-MeO DiPT; 4-methoxy-N,N-Diisopropyltryptamine; N-isopropyl-N-(2-(4-methoxy-1H-indol-3-yl)ethyl)propan-2-amine | C17H26N2O | 274.41 | 114 | 72 | 115 | 8.43 | show | WIVWUNUDMXNQJD-UHFFFAOYSA-N | RM-reference material | 2016-11-17 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1692-16 | |||
Opioids | Methoxyacetyl-F | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | Methoxy-AcF, Methoxyacetyl fentanyl | C22H28N2O2 | 352.48 | 261 | 158 | 218 | 11.87 | show | SADNVKRDSWWFTK-UHFFFAOYSA-N | test purchase | 2016-12-02 | RESPONSE project; 2015-2017 | 1733-16 | |||
Phenethylamines | MDA 2-aldoxime analog | N-[3-(2H-1,3-benzodioxol-5-yl)-2-methylpropylidene]hydroxylamine | alpha-Methyl-1,3-benzodioxole-5-propanal oxime; | C11H13NO3 | 207.23 | 135 | 77 | 51 | 5.36 | show | ISLHQWBNLXYVQG-UHFFFAOYSA-N | RM-reference material | (mixture of two isomers Z,E) | 2016-12-03 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1648-16 | ||
Cathinones | 4-CMC | 1-(4-chlorophenyl)-2-(methylamino)propan-1-one | 4-chloromethcatinone; clephedrone | C10H12ClNO | 197.66 | 58 | 111 | 75 | 3.81 | show | UEJBEYOXRNGPEI-UHFFFAOYSA-N | collected | 2016-12-06 | Hungarian Institute of Forensic Science, Budapest, Hungary | 1399-15 | |||
Opioids | U-49900 | 3,4-dichloro-N-[2-(diethylamino)cyclohexyl]-N-methylbenzamide | U-49900 | C18H26Cl2N2O | 357.32 | 112 | 153 | 86 | 10.19 | show | AXACJBKFKCCIOR-UHFFFAOYSA-N | test purchase | 2016-12-07 | RESPONSE project; 2015-2017 | 1734-16 | |||
Cathinones | alpha-PiHP | 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | α-PiHP | C16H23NO | 245.37 | 140 | 98 | 141 | 5.88 | show | UOZWZANRCOALQL-UHFFFAOYSA-N | test purchase | common name changed from alpha-PHiP to alpha-PiHP | 2016-12-07 | 2017-05-18 | RESPONSE project; 2015-2017 | 1723-16 | |
Others | RTI-111 | methyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | Dichloropane, 2β-Carbomethoxy-3β-(3,4-dichlorophenyl)tropane, O-401 | C16H19Cl2NO2 | 328.23 | 82 | 83 | 96 | 8.82 | show | AMIHUYQKNJHXPT-UHFFFAOYSA-N | test purchase | 2016-12-09 | RESPONSE project; 2015-2017 | 1722-16 | |||
Indolalkylamines (fe tryptamines) | DPT | [2-(1H-indol-3-yl)ethyl]dipropylamine | N-[2-(1H-indol-3-yl)]ethyl-N-propylpropan-1-amine | C16H24N2 | 244.38 | 114 | 130 | 115 | 7.57 | show | BOOQTIHIKDDPRW-UHFFFAOYSA-N | test purchase | 2016-12-09 | RESPONSE project; 2015-2017 | 1663-16 | |||
Cathinones | TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one | C19H27NO | 285.43 | 126 | 127 | 91 | 8.79 | show | MMIKQWIZKBYLKZ-UHFFFAOYSA-N | RM-reference material | 2016-12-09 | I-SEE project RM and report ( analysed in SI National Forensic Laboratory) | 1685-16 | ||||
Cathinones | alpha-PVT | 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one | α-Pyrrolidinopentiothiophenone | C13H19NOS | 237.36 | 126 | 127 | 111 | 5.84 | show | OOSRPGUQJAKBLV-UHFFFAOYSA-N | test purchase | 2016-12-09 | RESPONSE project; 2015-2017 | 1726-16 | |||
Phenethylamines | Proscaline | 2-(3,5-dimethoxy-4-propoxyphenyl)ethan-1-amine | 2-(3,5-dimethoxy-4-propoxyphenyl)ethanamine, 4-propoxy-3,5-DMPEA | C13H21NO3 | 239.32 | 167 | 168 | 210 | 5.93 | show | HYWLMSUAZVDUFW-UHFFFAOYSA-N | test purchase | 2016-12-12 | RESPONSE project; 2015-2017 | 1731-16 | |||
Arylcyclohexylamines | 3-MeO-PCE | N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine | 3-Methoxyeticyclidine | C15H23NO | 233.35 | 190 | 233 | 176 | 5.83 | show | OFGOOZLOGUNDFS-UHFFFAOYSA-N | test purchase | 2016-12-15 | RESPONSE project; 2015-2017 | 1732-16 | |||
Cathinones | alpha-PPP-MeO | 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | 1-(3-methoxy-1-oxo-1-phenylpropan-2-yl)pyrrolidine; 2-pyrrolidino-3-methoxy-propiophenone; alpha-PPP-MeO; PMeOPP | C14H19NO2 | 233.31 | 128 | 96 | 70 | show | TVBNCCGCIPGJQO-UHFFFAOYSA-N | analytical report | 2016-12-20 | CLEN2SAND project data provided by the European Commission Joint Research Centre (JRC), DG TAXUD and the CLEN | RPT: JRC-16090003 | ||||
Phenethylamines | 25B-NBOH | 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol | 2C-B-NBOH, NBOH-2C-B | C17H20BrNO3 | 366.25 | 179 | 280 | 73 | 11.35 | show | RSUNJYKZRKIBNB-UHFFFAOYSA-N | test purchase | GC-RT and MS spectrum refer for di-TMS derivative; nonderivatized cpd. decomposed to 2C-B | 2016-12-23 | RESPONSE project; 2015-2017 | 1697-16 | ||
Opioids | 2-Fluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | ortho-Fluorofentanyl; 2-FF; o-FF; o-fluorofentanyl | C22H27FN2O | 354.47 | 263 | 164 | 207 | 10.90 | show | BKUWDIVZCJNXRA-UHFFFAOYSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1701-16 | |||
Phenethylamines | UWA-101 | [2-(2H-1,3-benzodioxol-5-yl)-1-cyclopropylethyl](methyl)amine | α-cyclopropyl-MDMA | C13H17NO2 | 219.28 | 84 | 42 | 135 | 5.44 | show | DNROCNZQNQSVOG-UHFFFAOYSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1699-16 | |||
Others | W-19 | N-[(2Z)-1-[2-(4-aminophenyl)ethyl]piperidin-2-ylidene]-4-chlorobenzene-1-sulfonamide | W-18 metabolite | C19H22ClN3O2S | 391.91 | 119 | 106 | 111 | 18.91 | show | LPAZQXGIOLCCTG-QOCHGBHMSA-N | RM-reference material | 2017-01-05 | 2018-07-15 | RESPONSE project; 2015-2017 | 1703-16 | ||
Opioids | AH-8529 | 4-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide | C16H23ClN2O | 294.82 | 126 | 139 | 127 | 9.36 | show | NROYLFLWMSYSMA-UHFFFAOYSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1706-16 | ||||
Phenethylamines | 25B-NBOH | 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol | 2C-B-NBOH, NBOH-2C-B | C17H20BrNO3 | 366.25 | 179 | 280 | 73 | 11.30 | show | RSUNJYKZRKIBNB-UHFFFAOYSA-N | RM-reference material | GC-RT and MS spectrum refer for di-TMS derivative; nonderivatized cpd. decomposed to 2C-B | 2017-01-05 | RESPONSE project; 2015-2017 | 1700-16 | ||
Cathinones | Propylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one | 3',4'-Methylenedioxy-N-propylaminocathinone; Propyl-3,4-methylenedioxycathinone; PRONE | C13H17NO3 | 235.28 | 86 | 149 | 65 | 6.14 | show | YFVKHKCZBSGZPE-UHFFFAOYSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1705-16 | |||
Cannabinoids | 3F-AMB | methyl (2S)-2-{[1-(3-fluoropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanoate | methyl (1-(3-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate 3-fluoro AMP | C19H26FN3O3 | 363.43 | 233 | 145 | 304 | 10.04 | show | YPUVLRMGECVDHZ-VYIIXAMBSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1702-16 | |||
Cathinones | iPRONE | 1-(2H-1,3-benzodioxol-5-yl)-2-[(propan-2-yl)amino]propan-1-one | 3',4'-Methylenedioxy-N-isopropylaminocathinone; 1-(1,3-Benzodioxol-5-yl)-2-(propan-2-ylamino)propan-1-one | C13H17NO3 | 235.28 | 86 | 44 | 149 | 5.69 | show | ZGELXFOIEWJEFM-UHFFFAOYSA-N | RM-reference material | 2017-01-05 | RESPONSE project; 2015-2017 | 1704-16 | |||
Cathinones | 4_Methyl_PV8 | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)heptan-1-one | p-methyl-PV8; para-methyl-PV8: PV8 4-methyl analog | C18H27NO | 273.42 | 154 | 155 | 91 | 7.50 | show | ARMHZEVLKNFPAJ-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1714-16 | |||
Cannabinoids | 5-Bromo-THJ-018 | 1-(5-bromopentyl)-3-(naphthalene-1-carbonyl)-1H-indazole | 5-bromopentyl JWH 018 indazole analog; THJ 018 bromo analog | C23H21BrN2O | 421.34 | 127 | 271 | 155 | 16.95 | show | CHDPCRSBPAVUIZ-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1712-16 | |||
Phenethylamines | MMDA-2 | 1-(6-methoxy-2H-1,3-benzodioxol-5-yl)propan-2-amine | 2-methoxy-4,5-methylenedioxyamphetamine | C11H15NO3 | 209.25 | 44 | 166 | 151 | 4.87 | show | GPVJAXJRAZVITB-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1717-16 | |||
Others | Deschloro W-19 | N-[(2Z)-1-[2-(4-aminophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide | (Z)-N-(1-(4-aminophenethyl)piperidin-2-ylidene)benzenesulfonamide | C19H23N3O2S | 357.47 | 119 | 77 | 106 | 17.54 | show | LEPJQUCPARWIPK-VZCXRCSSSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1709-16 | |||
Cathinones | 5-Methoxymethylone | 1-(7-methoxy-2H-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | 2-A1MP ßk-MMDMA | C12H15NO4 | 237.25 | 58 | 56 | 179 | 6.51 | show | MPMHRFOOZMFFBD-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1752-16 | |||
Cathinones | 4-Chloropentedrone | 1-(4-chlorophenyl)-2-(methylamino)pentan-1-one | 4-CPD; 4-chloro-α-methylamino-Pentiophenone; 4-chloro-α-methylamino-Valerophenone | C12H16ClNO | 225.72 | 86 | 44 | 111 | 4.86 | show | OPCMVVKRCLOEDQ-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1708-16 | |||
Opioids | 4F-iBF | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 4-FIBF; FIBF; p-FIBF; 4-Fluoroisobutyrylfentanyl; para-Fluoroisobutyryl-fentanyl | C23H29FN2O | 368.50 | 277 | 207 | 164 | 10.75 | show | OZDOSQNUJIXEOR-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1710-16 | |||
Phenethylamines | 25H-NB4OMe | [2-(2,5-dimethoxyphenyl)ethyl][(4-methoxyphenyl)methyl]amine | 25H-NBOMe 4-methoxy isomer | C18H23NO3 | 301.39 | 121 | 150 | 122 | 9.51 | show | RIQSJIKRFRLJRV-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1711-16 | |||
Cannabinoids | MMB-CHMICA | methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3-methylbutanoate | AMB-CHMICA; methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)valinate; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carbonylamino)-3-methylbutanoate; | C22H30N2O3 | 370.49 | 240 | 256 | 144 | 13.48 | show | ROWZIXRLVUOMCJ-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1715-16 | |||
Opioids | 3-Fluorofentanyl | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 3-FF; m-FF; meta-Fluorofentanyl | C22H27FN2O | 354.47 | 263 | 164 | 207 | 10.74 | show | SLTQVWMQISKVDN-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1751-16 | |||
Cathinones | 3,4-Methylenedioxy-PV9 | 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)octan-1-one | MDPV three carbon homolog; Methylenedioxy-Pyrovalerone three carbon homolog | C19H27NO3 | 317.43 | 168 | 169 | 149 | 9.31 | show | SUZXRHPREJMNOG-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1716-16 | |||
Opioids | Valerylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide | NIH 10488; Pentanoyl fentanyl; Pentanyl fentanyl; Penta-Fentanyl; fentanyl pentanamide analogue; TCE; VF | C24H32N2O | 364.52 | 273 | 146 | 189 | 12.24 | show | VCCPXHWAJYWQMR-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1713-16 | |||
Opioids | AH-8533 | 2-chloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide | C16H23ClN2O | 294.82 | 126 | 139 | 127 | 9.12 | show | ZEXNERUNUXHAFO-UHFFFAOYSA-N | RM-reference material | 2017-01-06 | RESPONSE project; 2015-2017 | 1707-16 | ||||
Cathinones | 1-(4-methylphenyl)-2-(piperidin-1-yl)propan-1-one | 1-(4-methylphenyl)-2-(piperidin-1-yl)propan-1-one | C15H21NO | 231.34 | 112 | 113 | 41 | 5.97 | show | DHZOVKWINAURCF-UHFFFAOYSA-N | collected | Analytical report temporarily unavailable - 17/01/2017; Analytical report attached again 03/04/2014;Sample was synthesised and distributed by HIFS, Hungary in the frame of ENFSI-DWG PT 2016 | 2017-01-10 | 2017-04-03 | RESPONSE project; 2015-2017 | 1753-17 | ||
Opioids | Methene-U-47700 | 2-(3,4-dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)-N-methylacetamide | METHENE-U-47700; U-51754 | C17H24Cl2N2O | 343.29 | 84 | 125 | 71 | 10.29 | show | ISJUYFBACBKWBV-UHFFFAOYSA-N | test purchase | 2017-01-13 | RESPONSE project; 2015-2017 | 1729-16 | |||
Opioids | THF-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide | TETRAHYDROFURAN-F; THF-F; THF-fentanyl; Tetrahydrofuranylfentanyl | C24H30N2O2 | 378.52 | 287 | 71 | 146 | 13.87 | show | OHJNHKUFSKAANI-UHFFFAOYSA-N | test purchase | Analytical report updated: some analytical data (TOF, IC, NMR) added | 2017-01-13 | 2017-03-01 | RESPONSE project; 2015-2017 | 1659-16 | |
Phenethylamines | 3C-E | 1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine | 3,5-Dimethoxy-4-ethoxy-amphetamine | C13H21NO3 | 239.31 | 44 | 196 | 167 | 5.40 | show | AHLXCGRWNKUNTQ-UHFFFAOYSA-N | collected | 2017-01-27 | RESPONSE project; 2015-2017 | 1438-16 | |||
Phenethylamines | Methallylescaline | 2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethan-1-amine | MAL; 4-methallyloxy-3,5-dimethoxyphenethylamine | C14H21NO3 | 251.33 | 167 | 168 | 55 | 6.31 | show | FOXJFBFFGULACD-UHFFFAOYSA-N | collected | 2017-01-27 | Institute of Forensic medicine, University Freiburg, Germany | 1441-16 | |||
Indolalkylamines (fe tryptamines) | NDTDI | 3-({2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,8(12),9-tetraen-6-yl}(methyl)amino)-N,N-diethylpropanamide | N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide | C19H27N3O | 313.44 | 144 | 186 | 154 | 12.28 | show | JECGWOMOCPQHDH-UHFFFAOYSA-N | test purchase | 2017-02-06 | RESPONSE project; 2015-2017 | 1737-16 | |||
Cathinones | MPHP | 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one | 4'-Methyl-alpha-pyrrolidinohexanophenone, 4'-MePHP, 4'-Me-alpha-PHP, PV-4, 4-Methyl-2-pyrrolidinohexanophenone, PV4 | C17H25NO | 259.39 | 140 | 141 | 91 | 6.98 | show | YOSQVMGMENUCDX-UHFFFAOYSA-N | collected | 2017-02-13 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1762-17 | |||
Arylcyclohexylamines | Deschloroketamine | 2-(methylamino)-2-phenylcyclohexan-1-one | DXE, DCK, 2'-Oxo-PCM, 2-Phenyl-2-(methylamino)cyclohexanone | C13H17NO | 203.28 | 146 | 175 | 104 | 4.94 | show | ZAGBSZSITDFFAF-UHFFFAOYSA-N | collected | 2017-02-13 | Forensic Science Institute Zurich, Switzerland (NMR confirmed sample) | 1761-17 | |||
Cathinones | Dimethylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one | bk-MDDMA | C12H15NO3 | 221.26 | 72 | 65 | 73 | 5.40 | show | OSNIIMCBVLBNGS-UHFFFAOYSA-N | test purchase | 2017-02-16 | RESPONSE project; 2015-2017 | 1748-16 | |||
Cannabinoids | 5F-AKB-57 | adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | 5-flouro-APINAC, 5-fluoro AKB57, (3s,5s,7s)-adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate; | C23H29FN2O2 | 384.50 | 135 | 92 | 93 | 14.26 | show | FOBFXVSQNAVUMG-UHFFFAOYSA-N | RM-reference material | 2017-02-17 | RESPONSE project; 2015-2017 | 1757-17 | |||
Piperidines & pyrrolidines | 4-Anilino-1-Benzylpiperidine | 1-benzyl-N-phenylpiperidin-4-amine | NSC 76613, N-phenyl-1-(phenylmethyl)-4-piperidinamine | C18H22N2 | 266.39 | 91 | 173 | 172 | 9.01 | show | FSXGJIFBTBJMHV-UHFFFAOYSA-N | RM-reference material | 2017-02-17 | RESPONSE project; 2015-2017 | 1759-17 | |||
Piperidines & pyrrolidines | 4-Anilinopiperidine | N-phenylpiperidin-4-amine | C11H16N2 | 176.26 | 83 | 82 | 93 | 4.93 | show | LKRMTUUCKBQGFO-UHFFFAOYSA-N | RM-reference material | 2017-02-17 | RESPONSE project; 2015-2017 | 1758-17 | ||||
Benzodiazepines | Etizolam | 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | C17H15ClN4S | 342.85 | 342 | 344 | 313 | 13.79 | show | VMZUTJCNQWMAGF-UHFFFAOYSA-N | test purchase | 2017-02-17 | RESPONSE project; 2015-2017 | 1747-16 | ||||
Opioids | AH-7959 | 3,4-dichloro-N-{[1-(piperidin-1-yl)cyclohexyl]methyl}benzamide | C19H26Cl2N2O | 369.33 | 166 | 167 | 173 | 12.63 | show | WTOAYCRIVUCNNR-UHFFFAOYSA-N | RM-reference material | 2017-02-17 | RESPONSE project; 2015-2017 | 1756-17 | ||||
Indolalkylamines (fe tryptamines) | Ru-28306 | N,N-dimethyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,8,10-tetraen-6-amine | N,N-dimethyl-1,3,4,5-tetrahydrobenzo[cd]indol-4-amine | C13H16N2 | 200.28 | 200 | 144 | 154 | 7.05 | show | BQOANWOQEHVATQ-UHFFFAOYSA-N | test purchase | 2017-02-23 | RESPONSE project; 2015-2017 | 1755-17 | |||
Cannabinoids | NM-2201 | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | CBL-2201, 5-Fluoro-SDB-005 Indole | C24H22FNO2 | 375.44 | 232 | 144 | 212 | 17.08 | show | PRGFSQYZCKCBQO-UHFFFAOYSA-N | seized | 2017-02-23 | RESPONSE project; 2015-2017 | 1776-17 | |||
Opioids | Benzodioxole-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide | N-(1-phenethylpiperidin-4-yl)-N-phenylbenzo[d][1,3]dioxole-5-carboxamide, Benzodioxole-fentanyl, BZD-F | C27H28N2O3 | 428.53 | 149 | 337 | 150 | 18.53 | show | ZFAAZMIOHJNKGD-UHFFFAOYSA-N | test purchase | 2017-03-05 | RESPONSE project; 2015-2017 | 1672-16 | |||
Cannabinoids | 5F-3,5-ADB-PFUPPYCA | 2-{[1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazol-5-yl]formamido}-3,3-dimethylbutanamide | ADB-FUPYCA; 3,5-5-fluoro ADB-FUPPYCA; AZ-037 | C21H28F2N4O2 | 406.48 | 189 | 277 | 249 | 12.92 | show | CMXMZASHZSECQV-UHFFFAOYSA-N | RM-reference material | 2017-03-06 | RESPONSE project; 2015-2017 | 1765-17 | |||
Opioids | Cyclopentanyl-F | N‐phenyl‐N‐[1‐(2‐phenylethyl)piperidin‐4‐yl]cyclopentanecarboxamide | Cyclopentyfentanyl; Cyclopentyl fentanyl, CPF | C25H32N2O | 376.54 | 285 | 69 | 189 | 13.74 | show | PEASFKSPITUZGT-UHFFFAOYSA-N | test purchase | 2017-03-06 | 2017-04-18 | RESPONSE project; 2015-2017 | 1661-16 | ||
Cannabinoids | 5F-MDMB-PINACA | methyl 2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoate | 5F-ADB; 5F-methyl-AMB; 5-fluoro-MAMB; 5-fluoro ADB | C20H28FN3O3 | 377.46 | 233 | 145 | 289 | 10.64 | show | PWEKNGSNNAKWBL-UHFFFAOYSA-N | test purchase | 2017-03-06 | RESPONSE project; 2015-2017 | 1749-16 | |||
Cannabinoids | 5F-MDMB-PICA | methyl 2-{[1-(5-fluoropentyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate | 5F-MDMB-2201; MDMB-2201; | C21H29FN2O3 | 376.47 | 232 | 144 | 233 | 11.90 | show | CHSUEEBESACQDV-UHFFFAOYSA-N | test purchase | 2017-03-08 | RESPONSE project; 2015-2017 | 1777-17 | |||
Cannabinoids | 2F-NNEI | 1-(2-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | 2-fluoro MN-24; 2-fluoro NNEI | C24H23FN2O | 374.46 | 232 | 233 | 144 | 18.02 | show | HSKUHSPFXOBHMD-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | 2018-04-13 | RESPONSE project; 2015-2017 | 1772-17 | ||
Cannabinoids | ADB-BINACA | 2-[(1-benzyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indazole-3-carboxamide | C21H24N4O2 | 364.45 | 91 | 235 | 320 | 13.64 | show | IUFIUAWRCUVUCQ-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1767-17 | |||
Cannabinoids | 5Cl-THJ-018 | 1-(5-chloropentyl)-3-(naphthalene-1-carbonyl)-1H-indazole | 5-chloropentyl JWH 018 indazole analog; THJ 018 chloro analog; (1-(5-chloropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone | C23H21ClN2O | 376.88 | 127 | 271 | 375 | 16.13 | show | KLRDJQQYGMTILS-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1774-17 | |||
Cannabinoids | AB-BICA | (2S)-2-[(1-benzyl-1H-indol-3-yl)formamido]-3-methylbutanamide | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(phenylmethyl)-1H-indole-3-carboxamide | C21H23N3O2 | 349.43 | 91 | 234 | 235 | 15.71 | show | KWZMKPNXFPNTEJ-IBGZPJMESA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1769-17 | |||
Cannabinoids | MMB-FUBICA | methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}formamido)-3-methylbutanoate | FUB-AMB-indol, AMB-FUBICA; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine, methyl ester | C22H23FN2O3 | 382.44 | 109 | 252 | 268 | 13.21 | show | NYQOGZPXNJSYDW-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1773-17 | |||
Cannabinoids | ADB-BICA | 2-[(1-benzyl-1H-indol-3-yl)formamido]-3,3-dimethylbutanamide | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide | C22H25N3O2 | 363.46 | 234 | 91 | 235 | 15.88 | show | OGVITAUBEIIKNT-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1768-17 | |||
Cannabinoids | 4F-NNEI | 1-(4-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | 4-fluoro MN-24; 4-fluoro NNEI | C24H23FN2O | 374.46 | 232 | 212 | 144 | 18.48 | show | PSTMVUJRDHDKHN-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1771-17 | |||
Cannabinoids | MDMB-FUBICA | methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}formamido)-3,3-dimethylbutanoate | N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester | C23H25FN2O3 | 396.46 | 109 | 252 | 253 | 13.47 | show | RVAWIZIGOSKPBP-HXUWFJFHSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1766-17 | |||
Cannabinoids | 5F-Bepirapim | 3-(4-benzylpiperazine-1-carbonyl)-1-(5-fluoropentyl)-1H-indole | BZP-2201, NNL-2;(4-benzylpiperazin-1-yl)(1-(5-fluoropentyl)-1H-indol-3-yl)methanone | C25H30FN3O | 407.53 | 91 | 232 | 146 | 18.78 | show | WHHDMGMJHFYVEK-UHFFFAOYSA-N | RM-reference material | 2017-03-09 | RESPONSE project; 2015-2017 | 1770-17 | |||
Opioids | Furanyl norfentanyl | N-phenyl-N-(piperidin-4-yl)furan-2-carboxamide | N-phenyl-N-4-piperidinyl-2-furancarboxamide | C16H18N2O2 | 270.33 | 95 | 175 | 82 | 8.57 | show | DDSUGTXSJFAMIM-UHFFFAOYSA-N | RM-reference material | 2017-03-24 | RESPONSE project; 2015-2017 | 1781-17 | |||
Cathinones | 3-MEC | 2-(ethylamino)-1-(3-methylphenyl)propan-1-one | 3-Methylethylcathinone, 3-Methylethcathinone | C12H17NO | 191.27 | 72 | 44 | 91 | 3.76 | show | GEKLDGQKEZAPFZ-UHFFFAOYSA-N | test purchase | 2017-03-27 | RESPONSE project; 2015-2017 | 1724-16 | |||
Piperazine derivates | pFPP | 1-(4-fluorophenyl)piperazine | p-Fluorophenylpiperazine; flippiperazine; 4-FPP | C10H13FN2 | 180.23 | 138 | 180 | 122 | 3.89 | show | AVJKDKWRVSSJPK-UHFFFAOYSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1788-17 | |||
Opioids | 2-Fluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | ortho-Fluorofentanyl; 2-FF; o-FF, o-fluorofentanyl | C22H27FN2O | 354.47 | 263 | 164 | 207 | 10.90 | show | BKUWDIVZCJNXRA-UHFFFAOYSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1784-17 | |||
Cannabinoids | AMB-CHMINACA | methyl 2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-methylbutanoate | Methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)-3-methylbutanoate; MA-CHMINACA; AMB N-methylcyclohexyl analog; MAB-AB-CHMINACA | C21H29N3O3 | 371.48 | 241 | 145 | 312 | 11.65 | show | CRGGXDSTBHQLKJ-UHFFFAOYSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1790-17 | |||
Cannabinoids | MDMB-CHMINACA | methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoate | MDMB(N)-CHM; (S)-MDMB-CHMINACA; N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester | C22H31N3O3 | 385.51 | 241 | 145 | 131 | 11.82 | show | DGQMLBSSRFFINY-LJQANCHMSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1789-17 | |||
Arylalkylamines | M-ALPHA | [1-(2H-1,3-benzodioxol-5-yl)propyl](methyl)amine | Alpha-ethyl-N-methyl-3,4-methylenedioxybenzylamine; 1-methylamino-1-(3,4-methylenedioxy-phenyl)propane | C11H15NO2 | 193.25 | 164 | 42 | 165 | 3.81 | show | NLINVDHEDVEOMJ-UHFFFAOYSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1787-17 | |||
Cannabinoids | AB-001 | 3-(adamantane-1-carbonyl)-1-pentyl-1H-indole | JWH-018 adamantoyl derivative; JWH-018 adamantyl analog; 1-pentyl-3-(1-adamantoyl)indole; 1-Adamantyl-(1-pentyl-1H-indol-3-yl)methanone | C24H31NO | 349.52 | 214 | 144 | 215 | 14.14 | show | SHWDYCMMUPPWQM-UHFFFAOYSA-N | RM-reference material | 2017-03-31 | RESPONSE project; 2015-2017 | 1783-17 | |||
Piperazine derivates | pMeOPP | 1-(4-methoxyphenyl)piperazine | 1-(4-Anisyl)piperazine; 4-MeOPP; MeOPP; p-Methoxyphenylpiperazine | C11H16N2O | 192.26 | 150 | 192 | 120 | 5.50 | show | MRDGZSKYFPGAKP-UHFFFAOYSA-N | RM-reference material | 2017-04-04 | RESPONSE project; 2015-2017 | 1785-17 | |||
Cannabinoids | APICA | N-(adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide | JWH-018 adamantyl carboxamide; 1-Pentyl-N-(tricyclo[3.3.1.13.7]dec-1-yl)-1H-indole-3-carboxamide; SDB 001; 2NE1 | C24H32N2O | 364.53 | 214 | 144 | 307 | 16.56 | show | MDJYHWLDDJBTMX-UHFFFAOYSA-N | RM-reference material | 2017-04-06 | RESPONSE project; 2015-2017 | 1792-17 | |||
Phenethylamines | 2C-G | 2-(2,5-dimethoxy-3,4-dimethylphenyl)ethan-1-amine | 3,4-dimethyl-2,5-dimethoxyphenethylamine; 2-(2,5-dimethoxy-3,4-dimethylphenyl)ethanamine; 2,5-dimethoxy-3,4-dimethyl-benzeneethanamine | C12H19NO2 | 209.29 | 165 | 180 | 178 | 5.16 | show | NFOHGLKGLZIHJQ-UHFFFAOYSA-N | RM-reference material | 2017-04-06 | RESPONSE project; 2015-2017 | 1796-17 | |||
Cathinones | 4-BMC | 1-(4-bromophenyl)-2-(methylamino)propan-1-one | 4-Bromomethcathinone; Brephedrone; 4-BMAP; 1-(4-bromophenyl)-2-methylaminopropan-1-one; 1-(4-bromophenyl)-2-(methylamino)-1-propanone | C10H12BrNO | 242.12 | 58 | 56 | 76 | 4.50 | show | OOJXMFNDUXHDOV-UHFFFAOYSA-N | RM-reference material | 2017-04-06 | RESPONSE project; 2015-2017 | 1798-17 | |||
Cathinones | 3-BMC | 1-(3-bromophenyl)-2-(methylamino)propan-1-one | 3-Bromomethcathinone; 1-(3-bromophenyl)-2-methylaminopropan-1-one; 1-(3-bromophenyl)-2-(methylamino)-1-propanone; 3-BMAP | C10H12BrNO | 242.12 | 58 | 56 | 76 | 4.40 | show | PXLYROINIXKFAW-UHFFFAOYSA-N | RM-reference material | 2017-04-06 | RESPONSE project; 2015-2017 | 1797-17 | |||
Phenethylamines | 2C-F | 2-(4-fluoro-2,5-dimethoxyphenyl)ethan-1-amine | 4-fluoro-2,5-dimethoxyphenethylamine; 4-fluoro-2,5-dimethoxy-benzeneethanamine | C10H14FNO2 | 199.22 | 170 | 30 | 155 | 4.00 | show | QAVFEDRVOUKIPM-UHFFFAOYSA-N | RM-reference material | 2017-04-06 | RESPONSE project; 2015-2017 | 1795-17 | |||
Cannabinoids | 5F-3,5-AB-PFUPPYCA | 2-{[1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazol-5-yl]formamido}-3-methylbutanamide | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyra |